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In this thesis I focus on the development and application of hidden Markov model
(HMM) to solve problems in statistical genetics. Our method, based on a HMM,
models the joint haplotype structure in the samples, where the parameters in the
model are estimated by the Baum-Welch EM algorithm. Also, the model does not
require pre-defined blocks or a sliding window scheme to define haplotype bound-
aries. Thus our method is computationally efficient and applicable for either the
whole genome sequence or the candidate gene sequence.
The first application of this model is for disease association testing using inferred
ancestral haplotypes. We employed a HMM to cluster haplotypes into groups of
predicted common ancestral haplotypes from diploid genotypes. The results from
simulation studies show that our method greatly outperforms single-SNP analyses
and has greater power than a haplotype-based method, CLADHC, in most simu-
lation scenarios. The second application is for inferring haplotypic phase and to
predict missing genotypes in polyploid organisms. Using a simulation study we
demonstrate that the method provides accurate estimates of haplotypic phase and
missing genotypes for diploids, triploids and tetraploids. The third application is
for joint CNV/SNP haplotype and missing data inference. The results are very
encouraging for this application.
With the increasing availability of genotype data in both diploid and polyploid
organisms, we believe that our programs can facilitate the investigation of genetic
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1.1 Overview of thesis
This thesis focuses on the development and application of hidden Markov models
(HMM) for haplotype clustering to problems in statistical genetics. In Chapter 2, I
describe the model used in subsequent chapters. The first application of this model,
described in Chapter 3, is for disease association testing using inferred ancestral
haplotypes. This work was previously published in Bioinformatics (Su et al., 2008a).
We employ a HMM to cluster haplotypes into groups of predicted common ancestral
haplotypes. The approach is free from the assumption of a rigid block structure.
In Chapter 3, I review other methods for haplotype cluster-based association tests,
and present the results of a simulated study designed to compare our method with
existing methods given varied disease models. The second application is described
in Chapter 4 and was published in BMC Bioinformatics (Su et al., 2008b). We use
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the HMM to infer haplotypic phase and predict the missing genotypes in polyploids.
In Chapter 4, I present the results from a simulation study as well as a tetraploid
potato dataset. Chapter 5 describes the third application of the HMM for inferring
haplotypic phase, missing genotypes and allele configurations in CNV regions on
human chromosomes. In Chapter 6, I describe possible extensions and applications
of our model in the future.
1.2 Introduction and motivation
With the improvement of genotyping technology, many studies have shed light on
the relationship between genetic variation and biological function, which provides
fundamental insights into biology and evolution. The genetic variation can be ob-
served in many forms, such as variable number of tandem repeats, single nucleotide
polymorphisms (SNPs) and structure variations. Single nucleotide polymorphisms
(SNPs), the most common type of genetic variation occurring throughout the human
genome, have been widely used as markers in these studies. Recently, genotyping
SNPs with high density has become feasible and affordable. For instance, the hu-
man 1M Illumina chip is able to genotype more than 1.1 million loci per sample as
well as to detect known/novel CNV regions. Several public SNP databases (such
as Hapmap, WTCCC, and dbSNP) with millions of SNPs densely genotyped across
the genome are available. Also, the new-generation sequencing data is becoming
available, which enables us to conduct comprehensive analyses of genomes, tran-
scriptomes and interactomes with low cost.
The pattern of genetic variants helps to learn about evolutionary history and the
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genotype-phenotype relationship. Identification of variants that contribute to the
susceptibility for common disease leads to better strategies for diagnoses, prevention
and treatment. Different study designs and analysis methods have been developed
for mapping disease genes. Due to the availability of high-density SNPs through-
out the genome, many association studies are conducted on a genome wide scale
and their results have elucidated part of the genetic basis of many common diseases.
However, there are several statistical challenges for genome wide association studies,
such as how to deal with false positive associations, including those due to popula-
tion structure, and how to detect interaction between genes or between genes and
environment.
Single-SNP tests using the Armitage trend test or the Fisher exact test are the
most commonly used method in many association studies. As the current findings
in these studies only explain a small amount of variation in diseases, developing
a more powerful and computationally efficient method for testing disease associa-
tion is needed. Among many proposed approaches, haplotype-based methods are
promising. To solve the problem of the abundance of rare haplotypes (which might
result in the loss of power of haplotype-based method to detect disease association
due to a high number of degrees of freedom), haplotype clustering has become a re-
liable solution (see section 3.2.4). Haplotypes have played a key role in the study of
the genetic basis of disease. However, haplotypes cannot be observed directly from
genotype data and obtaining haplotypes via experiments remains expensive. Alter-
natively, statistically inferred haplotypes from genotypes have been widely used in
haplotype-based studies.
In this thesis, I mainly address two issues: disease gene association and haplo-
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type inference. The three proposed methods based on the HMM, implemented in
softwares AncesHC for detecting disease gene association, polyHap for inferring hap-
lotypic phase from polyploid genotypes, and modified polyHap for inferring CNV
haplotypes, will provide researchers a timely toolkit to further investigate genetic
variants in human and other polyploid species.
1.3 Basic genetics background
1.3.1 Single nucleotide polymorphism (SNP)
A SNP is single nucleotide variation at a specific location (marker) on the genome.
It results from a nucleotide-point mutation which has been maintained in the pop-
ulation. The frequency of the mutant allele is determined by evolutionary history
such as the age of mutation, positive selection or bottleneck events. By definition, a
SNP has a minor allele frequency of greater than 1% (Risch, 2000) in the population
of interest. A SNP is the most common form of known DNA variation, on average
occurring once per ∼ 300 base pairs in most populations (Botstein and Risch, 2003;
Carlson et al., 2003). The number of SNPs with minor allele frequency of greater
10% is approximately five million (Kruglyak and Nickerson, 2001). However, most
SNPs are thought not to alter the function such as the expression of a gene.
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1.3.2 Copy number variation (CNV)
Recently, structural variation (non SNP variation) has received increasing attention.
Structural variation is usually defined as the alteration of a DNA segment that is
larger than 1 kb (Feuk et al., 2006), such as variant copy numbers compared with
the reference genome. CNVs, including deletions, insertions and duplications, are
found abundantly throughout the human genome. The sizes of CNV regions vary,
and could cover entire genes and regulatory regions. They might have a considerable
biological impact and may play a role in complex disease susceptibility. With the
development of genotyping technologies and statistical/mathematical methods for
detecting CNV regions, copy numbers as well as CNV genotypes, the genome-wide
investigation and cataloging of CNVs are underway.
1.3.3 Haplotypes
In diploid organisms such as humans, each individual carries two copies of each au-
tosome (non sex chromosome), one of which is maternally and the other paternally
inherited. The ordered list of alleles on each chromosome copy is referred to as a
haplotype. Haplotype information is useful for mapping disease-gene association or
inferring linkage disequilibrium. It is also useful for studying evolutionary history
such as the identification of positive selection, gene conversion and inversions. How-
ever, haplotypes can not usually be determined directly from SNP genotype data




Figure 1.1: The ambiguity of haplotype phase observed from genotypes. From the
given genotypes, two possible haplotype phases can be resolved in this example.
Alleles strongly linked in a chromosomal region tend to be transmitted from gener-
ation to generation without recombination, which leads to a block-like structure of
haplotypes along the sequence. The results from the HapMap project suggest that
such haplotype blocks, comprised of common SNPs, occur in various sizes across the
human genome. Haplotype diversity within a block very likely arises from mutations
rather than ancestral recombination events. There is no agreed way to determine
the block boundaries so far, which may vary significantly between populations. For
example, the haplotype blocks tend to be shorter in African populations compar-
ing to non-African populations; and the block lengths are longer in the isolated or
inbreeding population comparing to the outbred population.
Ancestral haplotype
Here we use the mouse data to describe the idea of an ancestral haplotype depicted
in Figure 1.2. This mouse data are also used in one of the applications of our model
(described in Chapter 3). In this dataset, the outbred mice are descended from
eight inbred founders which carry eight different ancestral haplotypes. In Figure
1.2, different colours represent different ancestral haplotypes, which are partially
preserved in descendants under many generations of random mating. As such, the
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Figure 1.2: The ancestral process of forming the mosaic chromosomes of ancestral
haplotypes in the mouse data. There are eight inbred founders, where each ancestral
haplotype is represented in a different colour. After many generations of random
mating, the ancestral haplotypes are broken down by recombination and thus the
current haplotypes are observed in the mosaic of these ancestral haplotypes.
chromosomes of the current generation are a mosaic of ancestral haplotypes. The
greater number of generations between the founders and the current generation
would be expected to lead to a finer-grained mosaic in the current generation.
Although this is not the case in a natural population, the idea of developing mosaic
of ancestral haplotypes over many generations can still be employed in the human
genome. The ancestral haplotype here can be considered as the haplotype of the
most recent common ancestor when tracing back to a specific time. Thus, the hap-
lotypes of the current generation can be clustered into groups where the haplotypes
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within a group are assumed to have descended from the same recent ancestral hap-
lotype. In this thesis, we exploit this idea by modelling the ancestral haplotypes as
hidden states in the HMM.
1.4 Hardy-Weinberg Equilibrium (HWE)
In the absence of migration, mutation, natural selection and random drift, the geno-
type frequencies in the large random mating population are a simple function of
allele frequencies. This phenomenon is known as the ‘Hardy-Weinberg Equilibrium’
(Hardy, 1908; Weinberg, 1908). In the simple example of the genotype at a single
locus (with two allele) at HWE, the frequency distribution of genotypes over AA,
Aa, and aa in the population are p2, 2pq and q2 respectively, where p and q are the
frequencies of the allele A and a. One feature of HWE is that it is established in
one generation of random mating. Checking the deviation from the HWE on each
of observed genotypes has become a common practice in many studies. Significant
deviation from HWE may suggest the presence of population structure, genotyp-
ing errors, strong selection or extensive inbreeding in the dataset. The deviation
observed in the affected samples may indicate disease association with the tested
markers. Moreover, many genetic statistical models are developed under the as-
sumption of HWE. Testing the agreement of observed genotypes in the dataset with
HWE is one way to validate the use of these models (though some of these models
are not sensitive to the HWE deviation).
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1.5 Linkage disequilibrium (LD)
Linkage disequilibrium (LD) describes the dependence of alleles at different loci in
a population. The patterns of LD in the genome reflect the population history,
mutation events and other factors which affect the change of allele frequencies in
the population. Thus, the study of LD has been widely used both for investigating
evolutionary history and for mapping disease genes.
1.5.1 Measures of LD
The theory of LD in population genetics is well developed and different measures of
LD have been proposed (Devlin and Risch, 1995). The basic idea of these measures
is to consider the difference between the observed haplotype frequency at two loci
and the expected frequency if alleles are segregating independently. Consider a pair
of loci, where two alleles A/a and B/b are observed at loci 1 and 2 respectively in
the population. Assume that the haplotype phase of alleles is known and denote
PAB as the observed frequency of the haplotype carrying A and B alleles in the pop-
ulation. Under independent segregation between two loci, the expected haplotype
(AB) frequency is given by the product of marginal allele frequencies, PA. × P.B,
where PA. is the frequency of allele A at locus 1 and P.B is the frequency of allele B
at locus 2. So, one simple way to quantify LD is with D:
D = PAB − PA.P.B (1.1)
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However, the strong dependence of D on allele frequencies limits the use for com-
paring levels of LD along the genome. Alternatively, other measures of LD based
on D, such as D′ and r2, are less sensitive to the marginal allele frequencies.




min(PA.(1−P.B),(1−PA.)P.B) D > 0,
D
min(PA.P.B ,(1−PA.)(1−P.B)) D < 0.
(1.2)
D′ measures the evidence for recombination between the loci. The case of D′ = 1,
known as complete LD, is consistent with no recombination occurring between two
loci in the population. However, the estimate of D′ can be inflated by small sample
size. (In an extreme case, if the absence of one haplotype results from small sample
size, the estimation of D′ will be overestimated to 1.)
Another popular way to quantify LD is r2 (Hill and Robertson, 1968), the square of
the correlation coefficient, defined as
r2 =
D2
PA.(1− PA.)P.B(1− P.B) (1.3)
This measure represents the statistical correlation between two loci. The case of
r2 = 1 is stronger than D′ = 1. To distinguish this, we refer r2 = 1 as perfect LD. In
this case, one locus provides complete information about the other locus. Although
the estimate of r2 has no direct relationship with the evidence of recombination, it
shows less affected by sample size. Also, there is a direct relation between r2 and
the power of detecting association (Pritchard and Przeworski, 2001). Thus, r2 is
often used as the criterion for selecting tagSNPs in association studies (Montpetit
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et al., 2006).
Disease gene mapping
LD mapping of disease genes is based on the idea that when a causative mutation
occurs, the mutant allele is in high LD with the neighbouring SNPs and remains in
strong LD for many generations. Here a causative mutation increases the suscepti-
bility to a disease by altering the function of a gene. Consequently, disease genes can
be located by identifying ‘tagged’ SNPs that are closely linked to the mutant allele
if the causative SNP is not directly genotyped. The same idea of LD-tag SNPs also
has been exploited for mapping complex diseases in genome-wide association studies.
The majority of common genetic variants throughout the genome can be captured
by several hundreds of thousands of these tagged SNPs which are highly correlated
to several nearby SNPs. Thus, not every single base pair has to be genotyped to
locate the causative variants.
One way of defining haplotype block boundaries (described in previous section) is
based on the pattern of LD. A set of loci within a block are in strong LD with
each other. The association tests can be conducted based on this haplotype block
structure.
1.6 The coalescent
The genealogy of a sample of chromosomes from a population which has been evolv-
ing under the neutral Wright-Fisher model or other neutral models can be described
by the coalescent model. The genealogy is modeled back in time until the most re-
12 Chapter 1
cent common ancestor (MRCA). To sample a coalescent tree from a population, we
start at the leaves and randomly pick two descendants to ‘coalesce’. Mutations then
are superimposed on the branches of coalescent tree afterwards because a neutral
mutation does not affect reproductive success.
The coalescent tree can be thought of as the ancestral tree of a sample of chromo-
somes, describing how sequences are related back to a most recent common ancestor.
As the coalescent tree describes the genealogy of chromosomes, a genealogical tree is
used to represent the coalescent tree without the scale of time to coalescent events.
Sometimes, the terms ancestral/genealogical trees are used exchangeably.
1.6.1 The genealogical tree with mutation
First, consider a sample of haplotypes without recombination from a population.
Diversity of haplotypes is due to the mutations that occurred along the branches
of a tree. Mutant alleles may remain in the population until they become fixed or
lost by chance under neutrality or due to negative selection. Figure 1.3 describes a
genealogical tree with mutations resulting in 5 distinct haplotypes. The haplotype,
‘ATGGTCAGAATG’, is the most recent common ancestral haplotype.
1.6.2 The genealogical tree and recombination
Recombination in a chromosomal region is the exchange of two parental segments,
which causes the ancestral haplotypes to split. As the ancestral material of investi-
gated chromosome changes, the genealogy of a sample of recombinant chromosomes
1.6 The coalescent 13
Figure 1.3: Illustration of a genealogical tree of five haplotypes (1-5) with five mu-
tations, where each mutation is represented in a different color. The mutant alleles
are shown in bold, italic and underline letters. 0 haplotype is the most recent com-
mon ancestral haplotype. Lines L1 and L2 represent the places where ancestral
haplotypes are modeled (described in section 1.6.3).
cannot be described by a single tree, but a complex graph (Figure 1.4), called the
ancestral recombination graph, in which local genealogical trees are embedded (Hud-
son, 1983). As the sequence is read from one end to the other, the tree changes when
recombination occurs. The similarity of trees depends on the recombination rate in
the genomic region between them. If there is a recombination hotspot between two
loci, the genealogical trees of these two loci can be very different even if they are
close each other.
1.6.3 Approximation of the genealogical tree
The relationship between sequences and the underlying genealogical tree provides
us with a great amount of information to understand genetic variations. However,
the true genealogical tree underlying the observed chromosomes is unknown and the
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coalescent modelling is not computationally feasible for large scale datasets. Many
different approaches are proposed to approximate the genealogical tree by modeling
dependencies among the haplotypes. These dependencies may observe in a group of
haplotypes which have the same allele at many loci because of the shared ancesty.
In this thesis, we do not estimate the topology of the tree, but approximate the tree
by a structure reflecting shared genealogical ancestry. We cluster haplotypes into
groups which are corresponding to branches of the tree, where haplotypes within
a branch share the most recent common ancestor. For example, the tree in Figure
1.3 can be considered as a branch and thus the haplotypes 1 to 5 are clustered into
the one group, where the haplotypes 1 to 5 are all descended from the ancestral
haplotype ‘ATGGTCAGAATG’. On the other hand, if the more recent ancestries
are modeled, we can consider that the tree consists of two branches (illustrated by
horizontal line L2) where two ancestral haplotypes are modeled or four branches
(illustrated by line L1) where four ancestral haplotypes are modeled.
We treat these ancestral haplotypes as hidden states in the HMM and assign each
haplotype to one of the ancestral haplotypes. To deal with recombination events,
which results in different genealogical tree (Figure 1.4), the transition probability in
our model allows the membership of ancestral haplotypes change at each position
along the sequence according to the observed genotype data.
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Figure 1.4: Illustration of an ancestral recombination graph of five haplotypes with
an ancestral recombination event occurring on haplotype 3. Due to this recombina-
tion event, two segments of haplotype 3 are inherited from two different ancestries,
represented in red and blue colours, respectively. The lineages of these two segments
might coalescence with other chromosomes’ lineages in different ways, and thus re-
sults in different genealogical trees, as shown in red and blue trees. (The blue and




We now know that genetic information in DNA sequences is transmitted from gen-
eration to generation along with random occurrences of recombination events (and
other changes, such as gene conversion) which break down LD, and mutation events
which generate the observed diversity of haplotypes on the genome. An ancestral
haplotype is partially preserved in descendants. Thus, the underlying haplotype
structure is a mosaic of ancestral haplotypes (described in Figure 1.2). Here we
use a HMM to approximate the evolutionary history of these mosaic-like haplotypes
by clustering observed haplotypes into groups descended from the same ancestral
haplotype. Figure 2.1 shows the motivation. One colour represents an ancestral
haplotype which can be thought of as the most recent common ancestor of a branch













1     2   3       4    5 6    7   8
Figure 2.1: Changes in local tree due to recombination. The trees are constructed
from eight haplotypes. The occurrence of recombination leads to a different tree.
The idea of ancestral haplotypes exploited in our model is expressed in the mid-
dle tree. One colour represents one ancestral haplotype (the most recent common
ancestor).
(the number of ancestral haplotypes) decreases. Given this underlying genealogical
tree with 4 assumed ancestral haplotypes, the goal of the model is to cluster hap-
lotypes 1-8 to the group corresponding to their ancestral haplotypes. However, the
most appropriate number of ancestral haplotypes is unknown. The basic concept
is that to model rarer disease variants, a higher number of ancestral haplotypes is
appropriate. In this thesis, a first-order Markov chain is employed to model these
ancestral haplotypes, which are hidden states in a HMM, across the sequence. The
ancestral haplotype structure of chromosomes is then inferred by training the ob-
served sequences in framework of a HMM. Note that the training process in this
thesis is referred to a procedure of obtaining the parameter estimates in the HMM
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using the EM algorithm. We apply this model to three applications, haplotype
clustering for disease association, haplotype phase inference and missing genotype
imputation in polyploids as well as CNV haplotype inference.
2.2 Introduction to a HMM
2.2.1 Overview of a HMM
A hidden Markov model (HMM) is a probabilistic model which comprises an unob-
served Markov chain underlying the observations. A typical HMM can be charac-
terized by the following elements in the model (Figure 2.2): (1) The hidden state
sequence: unobserved states follow a first order Markov chain; (2) The observed
sequence: each observation is connected to an underlying hidden state; (3) The
transition probability and initial state distribution: two consecutive hidden states
in the HMM are modelled by the given initial distribution of hidden states and the
transition probability which models the jumps between hidden states; (4)The emis-
sion probability: the relation between hidden states and observed data is modelled
by the emission probability. Given this probability, the hidden state sequence is able
to generate an observed sequence.
There are three key issues when using a HMM (Baum and Petrie, 1966). Problem
1: how to efficiently calculate the probability of observed sequences given a HMM?
This probability is computed by summing over the probabilities for all possible
paths of hidden state sequence. However, the number of possible paths increases
exponentially with the length of sequence (Figure 2.3). One can imagine that directly
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Figure 2.2: Illustration of the generative model with a hidden state sequence. For
the case of diploid, a pair of ancestral haplotypes are treated as a hidden state in
the HMM (s1, . . . , sM). Each of connected hidden state generates the corresponding
genotype (g1, . . . , gM).
enumerating all possible paths is not practical, particular for a long sequence. This
problem is solved using the forward-backward algorithm (Baum et al., 1970).
Problem 2: how to find the most likely hidden sequence that generated the observed
sequences? One may be interested in uncovering the hidden part of the model, which
is the most probable path of hidden states given the observed sequences. Again, it
is impractical to examine each possible path. Alternatively, the Viterbi algorithm
(Viterbi, 1967) is a widely used method to find the most probable hidden sequence.
In this thesis, in addition to the Viterbi algorithm, a sampling approach is also used,
which generates a sample of paths based on the parameterised model, from which
the most likely hidden sequences are inferred.
Problem 3: how to estimate the parameters of a HMM given the observed se-
quences? The number of parameters in a HMM can be large when the sequence is
long and the model is unrestricted (transition and emission probabilities vary along
the sequence). We use the Baum-Welch training algorithm, a special case of the EM
algorithm, which provides a convenient way to estimate the parameters in a HMM
20 Chapter 2
Figure 2.3: An example of possible paths of hidden state sequences with the length
equals to 5 and the space of hidden state equals to 4. A black line from position 1
to 5 represents one possible path. The yellow line gives the most likely path.
by incorporating the forward-backward algorithm.
2.2.2 Application of a HMM
The HMM has been widely used in speech recognition, signal processing, image
analysis and economics since introduced in the late 1960s and early 1970s. This
model, first applied to biological sequence analysis by Churchill (1989), has become
one of the popular tools for modelling the evolution of DNA and amino acid sequence
(e.g. Krogh et al. (1994); Baldi et al. (1994)). However, there are limits to the
application of a HMM in DNA sequence analysis. For instance, a higher order
Markov chain might be desirable for modelling a complex structure.
Application in modelling LD
The HMM also has been used for modelling LD in a population sample. Li and
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Stephens (2003) employed a HMM to infer recombination rates and hotspots among
sequences. In their model, the transition probability is parameterized in terms of re-
combination rate and physical distance (assumed known) given the assumption that
the current haplotype hk+1 is an imperfect mosaic of observed haplotypes h1, . . . , hk.
The likelihood of observed haplotypes is constructed using the forward-backward al-
gorithm, and then recombination rates are estimated by maximising the likelihood.
Another application of the HMM to LD across multiple sites, introduced by Daly
et al. (2001), models haplotypes as a mosaic of four common ancestral haplotypes
(hidden states) which are identified by an initial scan for regions of low haplotype
diversity. The transition probability, representing the history recombination fre-
quency, is assumed invariant within a predefined block (region of low haplotype
diversity) and estimated by an EM algorithm. This study doesn’t directly estimate
the recombination rate between sites, but the frequency of transitions which pro-
vides a convenient summary of the degree of haplotype exchange between blocks,
and an alternative measure of LD.
Application in haplotype inference and missing genotype prediction
More recently, using a HMM to infer haplotypic phase or predict missing genotypes
has received much attention and several studies have shown the success of such
application (Scheet and Stephens, 2006; Kimmel and Shamir, 2005; Rastas et al.,
2005). In these approaches, the concept of a set of ancestral haplotypes is introduced
and incorporated in the hidden part of the model. These HMMs and our model
share several features but there are some differences among them (see section 2.5).
Another interesting application of a HMM is to phase and predict HLA alleles in
the MHC region on the human genome developed by Leslie et al. (2008). In their
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application, a set of resolved haplotypes (HLA alleles) are considered as hidden
states and a current haplotype is assumed to be a mosaic of these states. The
allele prediction is determined by the groups of resolved haplotypes with the highest
posterior probability.
2.3 Our model
We construct a HMM based on genetic sequences with ordered markers, where the
observed sequence is the genotype data and the hidden sequence is the underlying
ancestral haplotypes (Figure 2.2). First, we consider a HMM based on a haplotype
sequence, named ‘haploid HMM’. Each allele on the observed sequence is generated
by the underlying ancestral haplotype. We then extend this haploid HMM to a
polyploid HMM for modelling multiple chromosomes. Thus, our model has the flex-
ibility to model species of different ploidy— haploids, diploids, triploids, tetraploids,
and other higher ploids.
In the followings, I describe our probabilistic model in detail by the transition prob-
ability, the emission probability and the full probability.
2.3.1 Modelling ancestral haplotypes
For each individual we observe genotypes g = (g1, . . . , gM) at M SNPs along a
chromosome. For generality, let N denote the number of chromosome copies per
individual (so that N = 2 for diploid organisms). The genotype of an individual
is thought of as an unordered list of alleles, gm = {gm1, . . . gmN}, and each allele is
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assumed to have been derived from an ancestral haplotype, drawn from a fixed pool
of z distinct ancestral haplotypes. The unordered list of ancestral haplotypes at the
marker m is denoted by sm = {sm1, . . . , smN}. We will also denote by [sm1, . . . , smN ]
the ordered list of ancestral haplotypes; by pi(sm) = [smpi(1), . . . , smpi(N)] a permuta-
tion of this ordered list, and by Π(sm) the set of all such permutations. Thus, for
example, if sm = [1, 2] there are two permutations, namely [2, 1] and [1, 2], whereas
if sm = [1, 1] there is only one permutation. The sequence s = (s1, . . . , sM) forms a
Markov chain on the space of unordered lists of ancestral haplotypes. In this thesis,
we use ‘ancestral haplotype’, ‘cluster’ and ‘state’ exchangeably.
Transition probability
The two hidden states in the HMM are modelled by the given initial distribution
of hidden states and the transition distribution of states at two successive markers.
Recombination events are captured by transitions in the HMM, at which an indi-
vidual’s haplotype can switch the ancestral haplotype from which it is considered
to have descended. Gene conversion events are not modelled explicitly but can be
accommodated in our model by two proximal recombination events.
Transitions are allowed to occur continuously along the sequence. First we define
the transition probability in a haploid HMM from clusters kn to ln between markers
m−1 and m by
p(smn = ln|s(m−1)n = kn) =

(1− Jm) + Jmαmln ln = kn
Jmαmln ln 6= kn,
(2.1)
where Jm is the probability of a jump occurring at marker m−1. The probability
that this jump results in haplotype ln is αmln , irrespective of the current haplotype
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kn which means that “transitions” can occur that do not change the ancestral hap-
lotype. Recall that kn and ln are indices of ancestral haplotypes, and hence αm is a
probability vector with z elements. For tightly-linked markers, Jm is small so that
cluster changes occur infrequently, but are allowed between any pair of markers.
Based on this haploid model and under the assumption of HWE (i.e. haplotypes
making up each polyploid genotype are independent at each marker), the transition
probability amkl between unordered lists of clusters k = k1, . . . , kN and l = l1, . . . , lN
at marker m− 1 and m is given by




p(smn = lpi(n)|s(m−1)n = kn)
)
, (2.2)
Also note in equation (2.2) that we sum over permutations of the to ancestral haplo-
type. To understand this intuitively, consider first transitions between ordered lists
of ancestral haplotypes:
p(sm = [l1, . . . , lN ]|s(m−1) = [k1, . . . , kN ]) = ∏
n=1,...,N
p(smn = ln|s(m−1)n = kn). (2.3)
We can consider an unordered list of ancestral haplotypes as the collection of all or-
dered lists of ancestral haplotypes which are equivalent to each other under permu-
tation (in other words using the permutation operator to define equivalence classes
on the set of ordered lists of ancestral haplotypes). It is clear that the transition
probability from an ordered list of ancestral haplotypes [k1, . . . , kN ] to the unordered
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list of ancestral haplotypes {l1, . . . , lN} should be equal to the sum of the transi-
tion probabilities from the ordered list of ancestral haplotypes to all of the ordered
list of ancestral haplotypes comprising this equivalence class, which is just the sum
under all permutations as given in equation (2.2). Finally, we can see that this
ensures equal transition probabilities from each ordered list of ancestral haplotypes
[kpi(1), . . . , kpi(N)] to the unordered list of ancestral haplotypes {l1, . . . , lN}, and hence
we are able to use this as the transition probability from the unordered list of an-
cestral haplotypes {k1, . . . kn}.
Emission probability
The relation between hidden cluster and observed genotype data is modelled by
emission probabilities. As for the transition probability, the emission probability
of the polyploid HMM can be derived from a haploid model. For generality, we
assume multiallelic markers with alleles h ∈ {0, . . . , H}. Denote by θmln(h) the
emission probability of allele h in a haploid model at marker m given the ancestral
haplotype cluster ln. Under the HWE assumption, we then obtain the emission
probability eml(gm) of a genotype given an unordered list of ancestral haplotypes sm
by










If gm is completely missing for an individual at marker m, we set θmln(h) to be
uniform over all alleles. If gm is partially missing, we set θmln(h) to be uniform over
alleles that are consistent with the observed genotype at marker m.
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The haplotype of an observed individual is not an exact copy of the ancestral haplo-
type from which it has descended, because of evolutionary processes and imperfect
inferences. Thus the θmln(h) are generally different from zero and one, but they
should typically be close to one of these values.
Full probability of an observed genotype sequence
The probability of an observed genotype sequence g = (g1, . . . , gM) is obtained by
summing over all possible paths S of hidden states:
p(g|α, J, θ) =
∑
S





p(sm|Jm, αm, sm−1)p(gm|sm, θm)
(2.5)
where the transition and emission probability (the two terms of the product in the
equation) are determined by equation 2.2 and 2.4. Although the number of possi-
ble paths increases exponentially with the length of the sequence, the property of
Markov chain (the probability of current state is conditional independent of the pre-
vious state) allows this full probability to be computed efficiently using the forward
and backward algorithm which only increases computational cost linearly with the
length of the sequence.
2.3.2 Challenges
Block boundary
Many haplotype-based methods for detecting associations or models for inferring
haplotypes require predefined haplotype block boundaries. However, as discussed in
section 1.3.3, the best way to determine the block boundaries is not clear. In our
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method, the transition probabilities in the HMM strongly favour staying in the same
ancestral haplotype from one marker position to the next, but also allow switching
with a small probability which is learned from the data. Thus, the inferred ancestral
haplotype for each individual is able to switch at different positions, and there are
no predefined block boundaries. However, if a strong block-like structure exists in
a dataset, our model will (after the expectation-maximisation learning procedure)
learn the block structure and preferentially place transitions at block boundaries.
Unknown number of ancestral haplotypes
A challenge for our model is that we do not know the appropriate number of ancestral
haplotypes to include in our model in order to capture the principal causal variant
in a single ancestral haplotype. To allow for uncertainty in the correct number of
ancestral haplotypes, we use different number of ancestral haplotypes. We consider
2,4,6 and 8 ancestral haplotypes in the following applications. For computational
reasons we do not consider more than 8 ancestral haplotypes. A larger number of
ancestral haplotypes will be appropriate if the causal variant is rare, having arisen
on a lower branch of the genealogical tree.
2.4 Estimation and inference
As we mentioned previously, one of the key issues when using the HMM is how to
estimate a large number of parameters in the model. In this section, we describe
the methods used for the parameter estimation as well as the haplotype inference.
Here, we add a notation, i, to represent the index of individuals.
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Figure 2.4: Illustration of the construction of joint probability. The joint probability
of a genotype sequence s and transition event amkl are the multiplication of four
components (in dark blue)—fk(m− 1), amkl, eml(gm), bl(m).
2.4.1 Parameter estimation
To estimate the parameters in a HMM including Jm at each marker, as well as αmln
and θmln(h) at each hidden cluster and each marker, we use the EM algorithm, also
known as the Baum-Welch training algorithm, to find maximum-likelihood estimates
of these model parameters by employing the forward and backward probabilities.
Forward-backward algorithm
First, we specify the forward probability which is the joint probability of an observed
sequence up to and including gm−1 and the underlying state sm−1 at marker m− 1
(shown in left part in Figure 2.4) as fk(m − 1) = p(g1, . . . , gm−1, sm−1 = k). This
probability is obtained from the forward algorithm. The backward probability is
defined as bl(m) = p(gm+1, . . . , gM |sm = l) (in the right part of Figure 2.4).
The posterior probability of states k and l at markers m−1 and m given the observed
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sequence g is:
p(sm−1 = k, sm = l|g1, . . . , gM) = fk(m− 1)amkleml(gm)bl(m)
p(g)
(2.6)
where p(g) is full probability of the sequence, which can be computed efficiently by
the forward algorithm. Similarly, the posterior probability of state l at marker m
given the genotype sequence g is fl(m)bl(m)/p(g).
Expectation and maximisation
Based on the posterior probability decoding method, the expected counts of tran-
sitions from clusters k = {k1, . . . , kN} to l = {l1, . . . , lN} at marker m given the
observed genotype sequence g is obtained by the use of the forward-backward algo-





f ik(m− 1)amkleml(gim)bil(m) (2.7)
where i is the index of the sequence; f ik(m − 1) and bil(m) are the forward and
backward probability, respectively; amkl and eml(g
i
m) are the transition and emission
probability based on a polyploid HMM, respectively, which can be obtained from
equations (2.2) and (2.4).








The counts of transitions and emissions in a polyploid HMM are then decomposed
into counts of haploid based parameters— CJm , Cαmln and Cθmln (h) according to
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the permutation probabilities in equations (2.2) and (2.4). To avoid probability
estimates of 0 (over fitting), a small number (pseudo count) is added to each of
counts. The maximum likelihood estimates for Jm, αmln and θmln(h) with priors
of pseudo counts from Dirichlet distributions (maximum a posterior estimates with
Dirichlet priors) are given by
Jˆm =
CJm + uJ ∗ 0.5
(CJm + uJ ∗ 0.5) + (C1−Jm + uJ ∗ 0.5)
ˆαmln =
Cαmln + uα ∗ 1/z∑z
l=1(Cαmln + uα ∗ 1/z)
ˆθmln(h) =
Cθmln (h) + uθ ∗ 1/H∑H
h=1(Cθmln (h) + uθ ∗ 1/H)
(2.9)
where the terms uJ ∗0.5, uα ∗1/z, and uθ ∗1/H are the pseudo counts for estimating
parameters Jm, αmln and θmln(h) respectively. For this stage of model fitting, we set
uJ = uα = uθ = 0.01 for the first application and uJ = uα = uθ = 0.1 for the second
and third applications. The log likelihood value given observed genotype sequences
is calculated though the forward algorithm using these parameter estimates.
Computation of the training process
The training process might converge to a local maximum of the likelihood function,
which is a typical problem for the EM algorithm. A likelihood usually has many
local maxima, and different initial values for the EM algorithm could lead to different
local maxima (resulting in different parameter estimates). One way to deal with this
problem is to train the data with a fixed number of repetitions—each with different
initial values, and the parameter estimates can be obtained by one of the following
approaches: (1) the estimates are then selected from the repetitions that gives the
highest value of the log likelihood given the observed genotypes; (2) the estimates
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are then obtained by averaging over the estimates from all the repetitions; (3) the
estimates are then inferred by combining the results across different repetitions using
a sampling algorithm (see next section). In this thesis, we employed (1) and (3) with
10 repetitions of the training algorithm with different start values. Each repetition
of training has 25 iterations. According to our experience, 25 iterations in each
training process is able to give a reasonable good convergence.
Prior
For each initialisation of the EM algorithm, we use Dirichlet priors on all of our
parameters. Namely, for scalars uθ > 0 and uα > 0, we let θml. ∼ Dirichlet(uθmθ),
where mθ is the uniform vector with each element 1/H, and αm. ∼ Dirichlet(uαmα)
where mα is the uniform vector with each element 1/z. The u parameters measure
the strength of the prior information, so that large u implies sampling more tightly
around m.
Although Jm is considered as an unknown parameter and will be inferred from our
training algorithm, Jm can be expressed as a compound parameter, (1 − e−rmdm),
where dm is the physical distance and rm is the jump rate per bp between markers
m−1 and m. In general, rm is thought of as being related to the recombination
rate. However, Scheet and Stephens (2006) suggested that generally there might be
little correlation between actual recombination rate and estimates of rm. Here, the
Jm is considered as a single parameter in the training algorithm. Nevertheless, for
each initialisation of the EM algorithm, we set Jm ∼ Beta(uJ(1−e−dmr), uJe−dmr)
where uJ > 0 and dm (bp) is the distance between markers m−1 and m. We take
r = 10−8 per base pair in the population, reflecting the background probability of
recombination between consecutive bases.
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2.4.2 Inference
After estimating parameters in the HMM with the EM algorithm, we consider two
approaches for haplotype inference—the Viterbi algorithm and a sampling algo-
rithm. The computation of the Viterbi algorithm is standard. Here, I introduce our
sampling algorithm which provides a certainty measure for each haplotype estimate.
Sampling algorithm
After each repetition of the Baum-Welch EM algorithm, estimates of the parameters
of the HMM are obtained, which approximate a local mode of their joint posterior
distribution. For each individual, we then run the forward-backward algorithm us-
ing these parameter values to obtain a ‘trace’ matrix of the probability, conditional
on the model being in state l at marker m, of having arrived from state k at marker
m−1. We can then sample from the posterior distribution over state-paths condi-
tional on the non-missing genotype data of a given individual, by starting at the
‘end’ state, position M+1, and moving back towards marker 1, sampling the state
at the previous marker using the elements of this trace matrix. Each state in this
state-path consists of an unordered list of ancestral haplotype clusters. At each
marker we use equation 2.3 to sample a state of ordered haplotype clusters from
these unordered haplotype clusters. We then sample from the probability distri-
bution of ordered lists of alleles that are consistent with the genotype data at this
marker, given the ordered list of haplotype clusters. In the case of missing genotype
data, all possible ordered lists of alleles are considered. As ordered lists of alleles
are reconstructed, N haplotypes (recall that the ploidy is N) are then obtained.
Certainty calculation
2.4 Estimation and inference 33
In this section, I describe the algorithm for computing the certainty rate. A certainty
rate can be calculated for different levels of inference, including imputed genotype,
phased genotypes, unordered clusters, and ordered clusters. A pre-specified number
(e.g. 100) of haplotype assignments is calculated, as described above, for each
of a number (e.g. 10) of repetitions of the EM algorithm. From this a number
of haplotype assignments (e.g 1000 = 10×100) for each individual are obtained.
At markers with missing genotype data, the genotype that is sampled most often
is reported as the imputed genotype, and the fraction of times it is sampled is
reported as the ‘certainty’ of this estimate. Because we consider only a small number
(e.g. 10) of local modes of the posterior distribution for the HMM parameters, the
certainty value is not the probability of the imputed genotype under the model,
which would require integration over the posterior distribution, but it may serve
as a reasonable approximation to this probability. For the estimate of unordered
clusters, the estimated state (which consists of unordered list of haplotype clusters)
is the one sampled most often. The fraction of times it is sampled is then reported
as the certainty rate.
The algorithm to calculate the most likely phase assignment for an individual on
the basis of the set of sampled haplotypes proceeds from left to right. Consider a
heterozygous marker, say m. If there is no missing data, all samples from the HMM
have the same genotype at m; otherwise, we only consider samples which have the
most common genotype. We assume that the haplotype configuration for all of the
samples from the HMM is the same up to and including marker m−1, which is
trivially true of the first heterozygous marker. We count the number of times each
haplotype configuration (up to and including marker m) is observed, and return the
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configuration that is observed the most often as the phase assignment up to and
including marker m; and the fraction of times this is observed as the ‘certainty’
of this configuration. We then go through each of the samples and as necessary
introduce a switch between markers m−1 and m so that each of the samples now
has the same haplotype configuration up to and including marker m as the reported
configuration. At the stage of counting haplotype configurations, we note that it is
only necessary to count as far back as to identify N different haplotypes for each
sample. The similar procedure is conducted when calculating the certainty rate of
ordered haplotype clusters.
2.5 Comparison with other HMM methods
Three are other recently published haplotypic inference methods which use a similar
HMM as ours—Rastas et al. (2005) implemented in the software HIT, Kimmel and
Shamir (2005) implemented in the software HINT and Scheet and Stephens (2006)
implemented in the software fastPHASE. In this section, I compare the similarities
and main differences among these methods and our model. I will also compare our
method with Beagle (Browning and Browning, 2007, 2009), which based on a HMM
that locally clusters haplotypes.
2.5.1 Common features
First, the idea of using a fixed number of ancestral haplotypes as hidden states is
exploited in all methods. Each allele of a SNP is assumed to have descended from
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one of the ancestral haplotypes and thus each haplotype is formed from a mosaic of
these ancestral haplotypes. Usually, the appropriate number of ancestral haplotypes
is unknown. These methods investigate a variety of number of states.
The second similarity is that the block boundaries are flexible. For all the methods,
the transition probability is able to switch at different positions along the hidden
Markov chain of ancestral haplotypes. Thus, predefined block boundaries are not
required. Here, a transition between ancestral haplotypes can be thought of an an-
cestral recombination event between markers in these four models. However, the
model doesn’t connect directly with the observed genetic variation but the underly-
ing ancestral haplotypes instead. Therefore, it is not ideal using these four methods
to draw inference on the recombination rate.
Other two similarities are the assumption of HWE—alleles that make up each geno-
types are independent (this independence also holds for hidden states); and the
employment of the EM algorithm for inferring the parameters in the HMM.
2.5.2 Main differences
Our model is a general model which can deal with a variety of ploidy. On the other
hand, the other three methods are only for analysing diploids.
In terms of the purpose, we apply this model to cluster haplotypes for disease as-
sociation tests, to infer haplotypic phase and missing genotypes for polyploids and
to infer CNV haplotypes. Both HIT and HINT apply their models to haplotype
inference from diploid genotypes, while fastPHASE focuses on haplotype inference
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as well as missing-genotype imputation in the case of diploids.
For the algorithm of inference, we use either the Viterbi algorithm or a sampling
algorithm. Our sampling algorithm infers haplotypes and missing genotypes based
on that ‘sampled most often’ and provides a certainty rate for each estimate. Both
HIT and HINT used the Viterbi algorithm while fastPHASE sampled haplotypes
from their joint distribution, which is similar to our sample algorithm. fastPHASE
provides point estimates obtained from two methods. One is to select a pair of
haplotypes (for each individual) that appear most frequently in the sampled haplo-
types in order to maximize the probability of correctly inferring haplotypic phase for
the whole haplotype sequence. The other is to select a pair of haplotypes (at each
heterozygous site for each individual) sampled most often based on the previous
heterozygous site, which attempts to minimize the the proportion of heterozygous
sites that are phased incorrectly relative to the previous site.
For the problem of local maximum convergence, different strategies are used in these
four methods. HIT and HINT use some complex initialization strategies for their EM
algorithms to improve the convergence while fastPHASE approaches this problem
by averaging the results across the different repetitions of the EM algorithms. In
our approach, two strategies are considered. If the Viterbi algorithm is used for the
inference, we selected the results from one of 10 repetitions of the EM algorithms
which gives the highest log-likelihood value given the observed sequences, while if a
sampling algorithm is adopted, the results from 10 repetitions are considered (see
Section 2.4).
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2.5.3 Compare with Beagle
In Beagle, the observed haplotypes are grouped into clusters at each marker using a
HMM. The clustering membership tends to stay in the same at consecutive markers
based on similarity of local haplotypes. Beagle is first developed for inference of
haplotypic phase and missing observations from diploid genotypes of unrelated in-
dividuals (Browning and Browning, 2007). More recently, Browning and Browning
(2009) further extended their model, implemented in version 3 of Beagle, for impu-
tation and haplotypic phase inference for large datasets of both trios and unrelated
individuals. Similar to our model, an EM algorithm is also employed for estimating
the parameters in the model and recombination rate is not explicitly modeled in
the model. There are two major differences between our method and Beagle. First,
the number of clusters is fixed in our model, whereas Beagle allows the number of
clusters to vary at each marker. Second, Beagle will group haplotypes with different
alleles at a marker into different clusters, while our model might group them into
the same cluster. The inference of clusters in Beagle is based on current estimates
of haplotypes instead of on underlying ancestral haplotypes.
Chapter 3
Disease Association Tests by
Inferring Ancestral Haplotypes
3.1 Motivation and objectives
Most genome-wide association studies rely on single-SNP analyses to identify causal
loci. The high stringency required for genome-wide analyses (with per-SNP sig-
nificance threshold typically ≈ 10−7) means that many real signals will be missed.
Thus it is still highly relevant to develop methods with improved power at low type I
error. Haplotype based methods provide a promising approach; however, they suffer
from statistical problems such as abundance of rare haplotypes and ambiguity in
defining haplotype block boundaries.
We have developed an association method based on ancestral haplotype clustering,
implemented in software AncesHC, which addresses many of these problems. It can
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be applied to biallelic or multiallelic markers typed in haploid, diploid, or multi-
ploid organisms, and also handles missing genotypes. Our model is free from the
assumption of a rigid block structure but recognises a block-like structure if it exists
in the data. A HMM (described in Chapter 2) is employed to cluster the haplotypes
into groups of predicted common ancestral origin. We then test each cluster for
association with disease by comparing the numbers of cases and controls with 0, 1,
and 2 chromosomes in the cluster.
We demonstrate the power of this approach by simulation of case-control status un-
der a range of disease models for 1,500 outcrossed mice originating from eight inbred
lines. The results suggest that AncesHC has substantially more power than single-
SNP analyses to detect disease association, and is also more powerful than the cladis-
tic haplotype clustering method CLADHC. We also analyse a human dataset on the
chromosome 22 from the Wellcome Trust Case Control Consortium (WTCCC), and
show that AncesHC has greater power than single-SNP analyses 7in most simulation
scenarios.
3.2 Introduction
3.2.1 Introduction of genetic association study
Traditional linkage studies including genome-wide and candidate-gene linkage analy-
sis have proven to be successful for mapping the genes of simple Mendelian disorders.
However, for complex diseases such as Alzheimer, hypertension and diabetes, which
result from the interplay of multiple genes and environmental exposures, family-
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based linkage methods provide little power to detect the underlying genetic variants.
Only a few susceptibility loci or genomic regions for complex disease have been iden-
tified based on linkage studies (Thomson, 2001; Hirschhorn and Daly, 2005).
On the other hand, association-based methods using population genetic data are
expected to have greater power for the detection of small and moderate genetic ef-
fects for complex diseases, provided that the underlying variants are not too rare.
Although candidate-gene association studies have found some susceptibility loci for
complex diseases, many of these findings were not replicated by subsequent research
(Weiss and Terwilliger, 2000; Cardon and Bell, 2001). In addition, the identified risk
alleles only account for a small fraction of the total number of cases (Carlson et al.,
2004). One problem with candidate gene studies is that they rely on the ability
to predict plausible disease genes (Tabor et al., 2002; Hirschhorn and Daly, 2005).
When current biological knowledge cannot provide sufficient and convincing func-
tional genes, the candidate-gene approach will fail to find disease genes, especially
for complex diseases caused by many genes with small effects. These shortcom-
ings of the candidate gene approach suggest a need for well-designed strategies for
genome-wide association studies.
In genome-wide association studies, however, hundreds of thousands of genetic mark-
ers are required. With the discovery of considerable number of SNP markers and
technological advances in genotyping, comprehensive genome-wide scans of high
density markers have become feasible with large sample sizes to detect the modest
genetic effects for common diseases (Thomas et al., 2005). More recently, several
such studies using high-density genotyping in unrelated cases and controls have
been shown to be a successful approach for identifying common causal variants of
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moderate effect (e.g. WTCCC (2007); Sladek et al. (2007)).
There are many other computational and statistical challenges to be overcome in
order to efficiently use whole genome data to map multiple genes responsible for
complex disease. These may include keeping the false positive rate within accept-
able bounds; identifying the simultaneous effects of multiple causative loci, and the
important higher-order risk interactions including gene-gene interaction and gene-
environmental interaction; selecting tag SNPs; and correcting for population strati-
fications and cryptic relatedness.
The many possible approaches for identification of susceptibility loci in genome-wide
association studies fall broadly into two categories: single-point and multi-point ap-
proaches. A point could be any kind of marker, such as a microsatellite marker or
a SNP. We assume all of our markers are SNPs. However, the following discussion
applies also to other types of markers. First, I review single-SNP association tests.
I then discuss multi-point marker-based and haplotype-based association tests, re-
spectively. Finally, I introduce a recently popular method—imputation approach.
3.2.2 Single-point approach: single-SNP association test
Single-SNP association tests, such as the Fisher exact or the Armitage trend tests,
are the most convenient and popular method used in a genome-wide association
study. The Fisher exact test is powerful for most disease risk models but not op-
timally powerful under an additive genetic model for complex disease, while the
Armitage test (Armitage, 1955) calculates the risk of the three genotypes and tests
for a linear trend among these three risks. However, the Armitage test has low power
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if allelic effects are far from additive (Balding, 2006). One downside of single-SNP
tests is that they do not exploit correlations between neighbouring SNPs in order
to better capture the effects of untyped causal SNPs. In cases where the untyped
causal SNP is in weak LD with surrounding typed SNPs, this limits the power of
single-SNP analyses.
3.2.3 Multi-point marker-based approach
Regression models, such as a logistic regression, have been frequently used for map-
ping candidate genes. In a genome-wide association study, the number of marker
loci is usually larger than the number of individuals, in which case the regression
fails. One way to solve this problem is to use the stepwise selection technique. The
basic process is to progressively add the most significant variable to the model con-
ditional on all variables already in the model and remove variables which are no
longer significant conditional on other variables. An alternative choice is to impose
constraints on the regression coefficients, for example by shrinking the regression
coefficients toward zero and then minimizing the number of non-zero coefficients
in the model. Ridge regression (Hoerl and Kennard, 1970) minimizes the residual
sum of squares subject to a constraint term which is the sum of squares of the co-
efficients. This has the effect of shrinking regression coefficients for most markers
toward zero. However, ridge regression tends to keep all variables in the model.
Tibshirani (1996) proposed the Least Absolute Shrinkage and Selection Operator
(LASSO), which produces a sparse model by minimizing the residual sum of square
under a constraint on the sum of absolute values of the coefficients to be less than a
constant. It makes some of the coefficients exactly 0, and hence produces a subset
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selection of variables (markers).
3.2.4 Haplotype-based approach
Haplotypes are expected to capture much of the correlation structure among the
SNPs and can also encapsulate multiple tightly-linked causal variants (Schaid, 2004).
Haplotype-based methods typically use pre-defined windows of SNPs, together with
phasing software, to define haplotypes. Ideally, the windows would correspond to
haplotype blocks with strong LD between SNPs, and so their size should vary with
the background pattern of LD among SNPs. In practice, to apply these methods on a
genome-wide scale the windows are often of fixed size (number of SNPs) and “slide”
along the genome. In the followings, I introduce several different haplotype-based
approaches which can be conducted within each window.
Likelihood ratio test (LRT)
This approach constructs a LRT statistic to test equality of haplotype frequencies
between cases and controls. The LRT statistic is based on the multinomial likeli-
hood of haplotype frequencies, separately for cases, controls and cases and controls
combined. Morris and Kaplan (2002) applied the LRT to a case-control study in
the presence of multiple susceptibility alleles and reported that the haplotype-based
analysis can have a power advantage over the single-SNP analysis. One way to
obtain estimates of haplotype frequencies when haplotype phase is unknown is to
use the EM algorithm to maximize the likelihood of those frequencies under the
assumption of Hardy-Weinberg equilibrium (HWE). However, the departure from
HWE can bias estimates of haplotype frequencies (Fallin and Schork, 2000).
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Regression-based test
A variety of regression models are investigated to test and infer the effects of haplo-
types on the observed traits (Schaid et al., 2002; Zhao et al., 2003; Tzeng et al., 2006).
A flexible model is the generalized linear model (GLM), in which the dependent vari-
able is the observed trait and the haplotypes are treated as independent variables.
The link function in GLM can be specified by the types of traits, such as a linear
regression for the quantitative trait and a logit regression for the case-control study.
The design matrix of independent variables can incorporate the genetic model, such
as an additive, dominant or recessive model, as well as the covariate information.
Moreover, regression-based association methods can evaluate both the overall effect
of haplotypes which are in the model and the specific single haplotype effect on the
observed phenotype.
Haplotype clustering approach
One potential problem with the haplotype-based analysis is that multiple rare hap-
lotypes can lead to loss of power due to the many degrees of freedom. As a result,
single-SNP or multi-point marker based tests sometimes can be more powerful than
haplotype-based analyses (Clayton et al. 2004). One solution is to group haplo-
types based on similarity and perform statistical tests on these clusters (Molitor
et al., 2003; Seltman et al., 2003; Durrant et al., 2004; Li and Jiang, 2005; Morris,
2006; Waldron et al., 2006; Tzeng et al., 2006; Tachmazidou et al., 2007). These
approaches are motivated by the expectation that haplotypes within a cluster are
derived from the same ancestral haplotype and hence carry similar risks. The high
risk haplotypes with the same mutation share the more recent common ancestry,
which can be considered as a branch on the genealogical tree. Apart from inheriting
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the mutant allele, these haplotypes also intend to inherit alleles nearby the mutant
allele due to LD. Hence, these high risk haplotypes share more similarity than nor-
mal haplotypes and thus are more likely to be clustered in the same group under the
assumption of a single causal mutation. With much fewer clusters than haplotypes,
haplotype clustering based methods should provide more power than haplotyped-
based approaches which are not efficient with the abundance of rare haplotypes in
the dataset. The proposed haplotype clustering methods employed various scores
to assess haplotype similarity and clustered haplotypes into groups. A variety of
test statistics were then applied to test disease association with clusters in these
methods.
In the approach of Molitor et al. (2003), each cluster is determined by a haplotype
(centre) which could be considered as an ancestral haplotype. Each observed haplo-
type is then allocated to a cluster according to the distance to the centre, derived in
terms of a similarity score. The similarity score between a haplotype and a cluster
centre is expressed as the shared length identical by state (IBS). Given the assump-
tion that haplotypes in a cluster all have the same risk of the disease, an association
analysis is further performed by modelling risks of haplotype clusters. With the
grouping technique and estimation of haplotype cluster risks without assigning a
parameter to each haplotype, the degrees of freedom for the analysis are effectively
reduced. Waldron et al. (2006) further modified this method by approaching the
similarity score differently. Their similarity score is determined by a matching score
between a hypothetical ancestral haplotype and an observed haplotype. The like-
lihood is based on the numbers of cases and controls for each of the three possible
values for the number of alleles in the cluster at the apparent causal locus. This
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approach is fast to compute and, hence, potentially can deal with a large dataset.
The cladistic-based approach, on the other hand, incorporates a genealogical tree to
investigate the relationship of haplotypes determined by the shared ancestry chro-
mosome. In this approach, haplotype diversity is presented in a cladogram which
consists of several subgroups (clades). Each clade can represent a cluster of hap-
lotypes. Several methods based on this idea have been proposed. For example,
Durrant et al. (2004), implemented in software CLADHC, used standard hierar-
chical clustering techniques (Everitt, 1993) to construct a cladogram which can be
seen as analogous to a genealogical tree in a specific window of SNPs (the window
then slides, with overlaps, over the candidate region). At a causal locus, high risk
haplotypes are expected to be concentrated in particular clades in the cladogram.
The clustering proceeds from the foot of the cladogram where each clade consists of
a single distinct haplotype (this can be a group of chromosomes carrying the same
haplotypes) to the top of the cladogram where all haplotypes are in a single clus-
ter. The clusters of haplotypes are merged such that the mean pairwise haplotype
diversity (distance score) is minimized in the new clades. The similarity score is
the complementary allele frequency based on the idea that chromosomes sharing a
rare allele are expected to share more-recent ancestry than those sharing common
allele (and thus are considered more similar in terms of haplotype diversity). For
example, the similarity (allele sharing) is quantified by 1 − qm for sharing allele 1
at SNP m, where qm is the frequency of allele 1. After a cladogram is constructed,
a logistic regression is used at each partition level to conduct the association test
and search the best partition of the cladogram. The best partition of haplotypes in
the cladogram is selected by maximizing the evidence of disease association in the
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likelihood-ratio test. Liu et al. (2007) have proposed a weighted haplotype cladistic
analysis which weights the contribution of each SNP to the measure of haplotype
similarity based on CLADHC by the single-locus p-value of the SNP. To some extent,
this incorporates the information of disease outcomes to cluster haplotypes.
Coalescent approach
Clustering approaches are motivated by the idea that haplotype clusters reflect
aspects of the evolutionary history of case and control chromosomes. Coalescent-
based approaches more explicitly model this evolutionary history. Some methods
based on the coalescent have been proposed for fine mapping, and essentially ignore
recombination (Rannala and Reeve, 2001; Morris et al., 2002; Zollner and Pritchard,
2005). Minichiello and Durbin (2006) developed an approach that approximates
the coalescent-with-recombination model and that can be applied to larger regions.
However, applying these coalescent-based methods to a genome-wide association
study is extremely computationally demanding.
3.2.5 Imputation approach
A cost-efficient approach for the analysis of association—a genotype imputation
based method— has become increasingly popular. Several imputation programs are
proposed in these studies, such as TUNA (Nicolae, 2006), IMPUTE (Marchini et al.,
2007), BIMBAM (Servin and Stephens, 2007), SNPMstat (Lin et al., 2008) and
MACH (unpublished data). Some studies have shown improved power for detecting
disease association and the enhanced association signal with imputed genotypes
(Anderson et al., 2008; Marchini and Howie, 2008). The idea of the imputation
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based method is to impute genotype at ungenotyped markers using a reference panel
by exploiting the correlation (LD) among the typed and untyped SNPs, and then
to test disease association with both observed and imputed SNPs. The HapMap
data are usually used as a reference panel. However, the samples from the HapMap
project are only from a limited number of populations. The quality of imputation
may be reduced when the reference panel and the imputed (study) dataset are
from different populations. Recently, new-generation DNA sequencing technologies,
capable of processing millions of sequence reads in parallel, provide us the low cost
and high throughput sequence data (MacLean2009). Thus, much larger reference
panels for many populations are becoming available (such as from HapMap phase 3
and 1000 genome project), which can potentially improve imputation accuracy.
This imputation based method is also used to combine studies from different geno-
typing platforms in meta-analysis association studies (Lettre et al., 2008; Willer
et al., 2008; Zeggini et al., 2008). The imputation for untyped SNPs is conducted
on each dataset based on a reference panel which has genotype information on the
majority of markers for all platforms. Subsequently, the association can be evalu-
ated at the same SNPs in all datasets, which can facilitate the comparison of results
from different genotyping platforms.
3.2.6 Our approach
Here, we propose a haplotype-clustering approach based on a hidden Markov model
(HMM) that is more computationally-efficient than coalescent-based approaches but
without resorting to a sliding-window scheme or fixed haplotype blocks. We also
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propose a procedure for performing association tests on the haplotype clusters, using
a permutation strategy to obtain significance. Each haplotype cluster is represented
by an inferred ancestral haplotype, from which all haplotypes in the cluster are
assumed to have descended. We aim to identify the ancestral haplotype on which a
risk-enhancing mutant arose, so that cases are over-represented among individuals
with one or two chromosomes in the cluster. In this study, we assume a single causal
mutation, but our method can be extended to deal with multiple causal mutations.
Figure 3.1 illustrates the motivation behind our approach, for simplicity considering
the haploid case. Haplotype diversity within a small interval typically arises from
mutations (solid circles in Figure 3.1(A)) rather than from recombination events.
Thus, using clusters of haplotypes in association studies is useful because cases tend
to have similar haplotypes in the region surrounding a causal SNP. The genealogical
tree in Figure 3.1(A) is not directly observed, but if we can identify and test Cluster
1 (haplotypes H5-H8), consisting of haplotypes that share the causal mutant allele,
then we will have much greater power to detect the association than would be
possible from single-SNP tests. Specifically, based on the hypothetical haplotype
counts in Figure 3.1(B), the smallest Fisher exact test p-value from any of the typed
SNPs is 0.002, whereas testing cluster 1 against all other haplotypes gives p ≈ 10−11.
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 Locus  Frequency 
Haplotype 1 2 3 4 C 5 6 7 8 9 10  Case/Control 
H1 1 0 0 0 0 0 0 0 0 1 1  2/8 
H2 0 1 0 0 0 0 0 0 0 1 1  2/8 
H3 0 0 1 0 0 0 0 0 0 0 1  2/8 
H4 0 0 0 1 0 0 0 0 0 0 1  2/8 
H5 0 0 0 0 1 1 0 0 0 0 1  8/2 
H6 0 0 0 0 1 0 1 0 0 0 1  8/2 
H7 0 0 0 0 1 0 0 1 0 0 1  8/2 
H8 0 0 0 0 1 0 0 0 1 0 1  8/2 
Cluster 3 0 0 0 0 0 0 0 0 0 0 1  4/16 
Cluster 4-5 0 0 0 0 0 0 0 0 0 0 0  12/48 
**11104.1 −×=p  
*: single-SNP analysis 





 H1 H2 H3 H4   H5  H6      H7 H8 










(Cluster 3)                                                         (Cluster 4)    (Cluster 5) 
*209.0=p  
#Cases:      4                       8                      32                                   4                      8 
#Controls:  16                    32                     8                                    16                    32 
 
*002.0=p  
Figure 3.1: A genealogical tree (A) and eight haplotype sequences from the leaves
of part of this genealogical tree indicated by solid lines. Mutations are marked by
black dots with a number specifying its marker position. The untyped causal allele
is marked by a ’C’. We have delineated 5 ancestral clusters. The rows of #Cases
and #Controls specify the number of cases and controls among these clusters. The
count of each haplotype by cases and controls is given in the table (B). We aim to
cluster together haplotypes H5, H6, H7, H8 using our model, and subsequently test
association of this cluster with case/control status. The Fisher exact test p-value of
each SNP based on a single SNP analysis is 0.004 (based on SNP1-8), 0.209 (SNP9)




In this chapter we assume a diploid organism (N = 2). We use a HMM (described in
Chapter 2) to transform the genotype (unordered pair of alleles) for each individual
at each marker into an unordered pair of ancestral haplotypes using 2, 4, 6 and 8
ancestral haplotypes respectively.
The Dirichlet priors are used on all parameters in the model training process as
described in Chapter 2. The degree of informativeness of the prior can be controlled
by the parameter—scalars (u) in the Dirichlet distribution. A smaller scalar implies
that the prior is less informative, where the prior is close to an uniform distribution.
In this application, we use uθ = uα = uJ = 2 to initialise the model; subsequently
we set uθ = uα = uJ = 0.01 for model fitting.
3.3.2 Association tests
This section describes how we use the transformed dataset to conduct association
tests. Note that the ancestral haplotypes may remain unchanged over a set of
consecutive SNPs for all individuals in the dataset. In this case the test statistic
will be invariant over the set of SNPs, and hence we can perform a single test. We
will call a set of SNPs a ‘haplotype block’ if there is no change of ancestral haplotype
for any individual, whether using 2, 4, 6 or 8 distinct ancestral haplotypes (Figure
3.2).
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Figure 3.2: Illustration of the haplotype block structure inferred using 2, 4, 6 and 8
distinct ancestral haplotypes for 63 SNPs (409th-472th) in the mouse data set used
in this Chapter (see section 3.4.1). Different rows represent different numbers of an-
cestral haplotypes. In a given row, changes in shading as we move left to right along
the chromosome represent a change of ancestral haplotype for any individual in the
dataset. The solid lines between markers represent the definition of the haplotype
block boundaries, which correspond to any change of ancestral haplotype for any
individual in any of the models using 2,4,6 and 8 distinct ancestral haplotypes.
Since there are z ancestral haplotypes, we compute τ , the association test statistic,
z times in each block, treating each ancestral haplotype in turn as the high-risk
haplotype. We repeat this process for z = 2, 4, 6, and 8, and retain the maximum
test statistic over all 20 possibilities for the high-risk ancestral haplotype. Here,
the Armitage trend test is used as our test statistic (τ), but any other test statistic
can be equally applied based on the 2 × 3 table representing the numbers of cases
and controls with 0, 1, and 2 predicted copies of the putative high-risk ancestral
haplotype. We explain the full procedure underlying AncesHC step by step in Figure
3.3. Type 1 error is assessed by repeating the (computationally fast) steps (D) to
(F) under random permutations of case-control labels: since the computationally-
demanding steps (A) through (C) do not involve phenotype labels, they do not




(F) Maximum test statistics=max {τ1, τ2, τ3, τ4} 
 
HMM 
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Contingency Table for Each State 
 0 copy of S* 1 copy of S* 2 copy of S* Total 
case r0 r1 r2 R 
control t0 t1 t2 T 
Total n0 n1 n2 N 
*=1, 2, 3, and 4 
Genotype Data 
Ind 1: 021221010  
Ind 2: 210112001 
Ind 3: 021221201  
 
 
Ind 1_1: S1S1 S3S3S3S3S3 S4S4S4S4S4S4 
Ind 1_2: S3S3 S3S3S3S3S3 S1S1S1S1S1S1 
Ind 2_1: S1S1 S2S2S2S2S2 S4S4S4S4S4S4 
Ind 2_2: S4S4 S3S3S3S3S3 S1S1S1S1S1S1 
Ind 3_1: S1S1 S3S3S3S3S3 S2S2S2S2S2S2 
Ind 3_2: S1S1 S1S1S1S1S1 S4S4S4S4S4S4 
 
Causative block Flanking block Flanking block 





















*=1,2,3, and 4 
Armitage Trend Test (E) 
Figure 3.3: This graph explains the process of our method in the case of z = 4
ancestral haplotypes. (A) Genotype data are coded as 0,1, and 2. (B) Illustration
of possible jumps from ancestral haplotype 1 at SNP 1 to the other 4 ancestral
haplotypes at SNP 2. (C) The inferred ancestral haplotypes where we can observe
the block-like structure of these sequences. The target region in the simulation study
is defined as the causal block and its two flanking blocks. (D) The contingency table
for one (putative high-risk) ancestral haplotype in one block. (E) The formula for
the Armitage trend test statistic. (F) The maximum test statistic over the four
ancestral haplotypes.
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3.4 Application of AncesHC to a mouse dataset
We applied AncesHC to a mouse dataset (detailed in section 3.4.1). For the hidden
sequence inference, we used the Viterbi algorithm to find the most probable ancestral
haplotype sequence given the parameterised model (where parameters are estimated
by the EM algorithm). Thus, the association tests are conducted without considering
the certainty rates of inferred ancestral haplotypes.
We compared the performance of AncesHC with single-SNP tests and the cladistic
haplotype clustering method CLADHC (Durrant et al., 2004). The reasons for
choosing CLADHC among the many haplotype-based methods available are that it
is computationally feasible for a large scale dataset, and that Bardel et al. (2005)
found that it performs generally well against other similar methods.
We simulated disease status for a mouse dataset on the basis of a range of disease
models and a range of causal loci (which are subsequently removed for inference).
The results suggest that AncesHC has substantially more power than the single-
SNP Armitage trend test to detect association with disease, and more power than
haplotype clustering analysis using CLADHC for most of simulation scenarios.
3.4.1 The mouse dataset
We used a mice dataset consisting of 1,904 outbred mice descended from eight geno-
typed inbred founder strains (Valdar et al., 2006), having been maintained under
random mating for more than 50 generations, thus generating mosaic-like chromo-
somes (Figure 1.2). SNPs were typed across all 19 chromosomes and the X chro-
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mosome. The dataset was provided by Richard Mott (Wellcome Trust Centre for
Human Genetics, Oxford). The mean interval between markers on those chromo-
somes is 204 kb with standard deviation 231 kb. In this application, we only used
the SNPs on chromosome 1.
One of the features of the mice dataset is that the founders have been genotyped and
so we can accurately infer the founder haplotypes: we will refer to these as “known”.
The performance of tests using these known ancestral haplotypes provides a good
benchmark for AncesHC, which must usually infer the ancestral haplotypes without
information about the founder strains.
3.4.2 Simulation
Before introducing our simulation algorithm, I first give a brief note of applying
CLADHC to the mouse dataset. CLADHC uses SNP haplotypes, which we obtained
for the mouse dataset using fastPHASE (Scheet and Stephens, 2006). We used
fastPHASE and not AncesHC so that the comparison was completely independent
of AncesHC. One CLADHC input parameter is the number of SNPs in a haplotype
window: we considered windows of size 4,6,8 and 10, as used by Durrant et al.
(2004), and found that the maximum window size of 10 gave the best results, which
we report.
Simulation procedure
We simulated disease status on the mouse data using 1,500 mice with low levels
of missing data and all 946 SNPs on chromosome 1 after removing monomorphic
SNPs. We used two disease models, each assuming a disease prevalence of 12% and
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a single high-risk minor allele, with genotype relative risks (GRR) in the ratios 1:2:4
and 1:3:3, respectively. Thus, 180 cases are expected from the 1,500 mice, and we
randomly sub-sample to obtain 150 cases and 150 controls. For each disease model
we randomly chose 24 causal SNPs, eight in each of three disease allele frequency
(DAF) bands: 3–6%; 7–10% and 15–17%. We analysed 100 datasets generated
under each of these 48 (24 putative loci for each of 2 disease models) scenarios, and
averaged the results across SNPs within each disease model and DAF band. We
removed the 24 causal loci from all simulated datasets, as well as 49 SNPs in strong
LD with any of them (r2 ≥ 0.8), when performing ancestral haplotype inferences,
phasing for CLADHC by fastPHASE, and all association tests. We do not remove
any SNPs when inferring transition probabilities with known ancestral haplotypes, in
order to have more precise estimation of the ‘true’ haplotypes, but we removed these
73 SNPs when performing association tests using the known ancestral haplotypes.
Permutation and power
For each of 48 scenarios, we generated 10,000 permutation datasets by randomly
choosing 150 cases and 150 controls from all 1,500 mice. From each permutation
dataset we calculate the statistics for each block from AncesHC, and each SNP from
single-SNP Armitage trend tests and CLADHC. This generates an empirical null
distribution of each statistic, which we use to compute approximate p-values for the
statistics calculated in each of the 100 datasets for that scenario.
To assess the power of each method, we regard a significant test statistic to corre-
spond to a true positive if it arises in the block that includes the causal SNP, or in
either of its two flanking blocks. For each method, I calculate the minimum p-value
(minP) over these three blocks for each of the 100 datasets and 48 scenarios.
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Computation
We also attempted to compare AncesHC with Margarita (Minichiello and Durbin,
2006), but found it to be too computationally demanding for our simulation study.
We found that Margarita required 10-11 hours for a single dataset consisting of
873 SNPs and 300 mice (using 10,000 permutations to assess significance and 100
ARGs). AncesHC is much more efficient for the simulation study because the
computationally-intensive steps, (A) to (C) in Figure 3.3, do not depend on the
case-control labels and hence need be employed only once for the entire simulation
study. For the ancestral haplotype inferring step, the computing time of AncesHC
with 873 SNPs and 1500 mice is approximately 3 h, 2 h, 30 min, and 10 min for 8, 6,
4, and 2 ancestral haplotypes, respectively, for each repetition of the EM algorithm
(we perform 10 repetitions of the EM training algorithms in this application).
3.4.3 Results
We first compared the LD structure for the mouse chromosome 1 data to CEU EN-
CODE data on Chromosome 2 (a 500kb segment). For both datasets, we excluded
the SNPs which have minor allele frequency < 10% when calculating r2. We ob-
serve that randomly selected pairs of SNPs in the mouse dataset at a distance of
approximately 3Mb have an average r2 of 0.2, corresponding to a distance of 50kb
in the ENCODE dataset. Thus, the average intermarker spacing of 190kb in the
mouse dataset roughly translates to a 3kb spacing in a human dataset. Although
this comparison is limited to these two datasets, it give us a flavour of the difference
between the human and mouse data.
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Figure 3.4 presents the power of each test in the simulation study as a function of
significance level (type I error) for the six combinations of disease model and DAF
band. The power of AncesHC with inferred ancestral haplotypes is comparable to
that obtained with known ancestral haplotypes, except for rare variants (DAF 3–
6%). This suggests that our HMM clustering algorithm in general performs well.
AncesHC outperforms the single-SNP analysis for both disease models in all three
DAF bands. It also has greater power than CLADHC for almost all scenarios.
Although we show the power from significance level of 10−4, a more reliable power
assessment can be obtained at significance level of 10−3 as we only conduct 10,000
permutations in this study. Table 3.1 shows the empirical power at significance level
of 10−3 in Figure 3.4. Underlying each power estimate are 800 simulated datasets
(each dataset contains a causative SNP and 100 replicates for each of eight causative
SNPs), so the standard deviation of the estimate is about 1.7% when power ≈ 50%.
In Figure 3.5, we report the corresponding results when the 49 SNPs in high LD
with one of the 24 causal SNPs are also included in the marker set. For both disease
models, the power of AncesHC is similar to that obtained without the high-LD SNPs
(Figure 3.4), whereas the performance of the single-SNP analysis is greatly improved
when these SNPs are included, especially for rare and intermediate variants (DAF
3–9%). AncesHC remains more powerful overall, but this analysis illustrates that
its principle advantage over single-SNP tests arises when the causal SNP is not well-
tagged by the marker SNPs. Table 3.2 shows the empirical power at significance
level of 10−3 in Figure 3.5. Including the 49 high-LD SNPs improves the power of
CLADHC, only slightly when the window size is 4, but greatly when the window
size is 10 and disease variants are common (Figure 3.5).
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In Figure 3.6, we show the power of AncesHC when restricted to a fixed number (z =
2, 4, 6, or 8) of distinct ancestral haplotypes, as well as when taking the maximum
over these cases. For z fixed, the case z = 8 is usually close to optimal, but taking
the maximum over z in most scenarios gives a further noticeable improvement.
Since computational time is proportional to the square of the number of ancestral
haplotypes, considering smaller values of z is computationally cheap relative to the
cost of implementing z = 8.
Disease models Testing methods
GRR* DAF** Known AncesHC Inferred AncesHC CLADHC Single SNP
3-6% 0.071 0.049 0.053 0.028
1:2:4 7-9% 0.288 0.268 0.221 0.105
13-15% 0.495 0.511 0.410 0.364
3-6% 0.476 0.383 0.330 0.136
1:3:3 7-9% 0.720 0.681 0.630 0.305
13-15% 0.801 0.803 0.668 0.570
Table 3.1: Numerical values of the power of the four methods at 10−3 type I error





































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































3.5 Application of AncesHC to the WTCCC dataset 63
Disease models Testing methods
GRR* DAF** Known AncesHC Inferred AncesHC CLADHC Single SNP
3-6% 0.071 0.059 0.054 0.100
1:2:4 7-9% 0.290 0.238 0.243 0.305
13-15% 0.483 0.455 0.450 0.360
3-6% 0.500 0.430 0.373 0.345
1:3:3 7-9% 0.710 0.680 0.669 0.626
13-15% 0.803 0.731 0.719 0.566
Table 3.2: Numerical values of the power of the four methods at 10−3 type I error
in Figure 3.5. GRR*: genotype relative risk. DAF**: disease allele frequency
3.5 Application of AncesHC to the WTCCC dataset
We applied AncesHC to a large-scale genomic dataset from the WTCCC. For the
hidden sequence inference, we used a sampling algorithm to infer the ancestral hap-
lotypes along the chromosome (see Chapter 2), which provides the certainty rate for
each estimate. Here, the certainty rates are incorporated in the tests. For the mouse
dataset, as we used the Viterbi algorithm rather than this sampling algorithm, the
certainty rate was not computed.
In this application, we focus on comparing the performance between AncesHC and
the single-SNP test. For AncesHC test, we consider two scenarios—with and without
the incorporation of the certainty rate of each inferred ancestral haplotype in the
association test.
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We simulated disease status for the human dataset on the basis of a range of disease
models. The results suggest that AncesHC is slightly more powerful than single-SNP
tests in most simulation scenarios.
3.5.1 The human dataset
We considered the chromosome 22 dataset consisting of 6206 SNPs. We included
1500 individuals from the 1958 British Birth Cohort for analysis. To simplify the
computation, we did not include the individuals from the UK Blood Service Control.
Extension of haplotype association statistic to incorporating ancestral
haplotype uncertainties
The probability distribution over all ancestral state pairs is computed by AncesHC
when the sampling algorithm is adopted for haplotype inference. In this section we
consider only the three most likely ancestral pairs at each locus for each individual,
and we re-weight these probabilities to sum to 1. The number of cases and controls
with 0, 1 and 2 copies of the putative causative haplotype are then weighted by these
three re-weighted probabilities when conducting the Armitage trend test. This may
not be the best way to incorporating our certainty scores. Later, we describe a
better approach by considering the certainty scores of all possible ancestral pairs in
section 3.7. Table 3.3 gives an example of weighting the counts based on certainty
rates for the putative risk haplotype 1. We show the top three highest certainty
rates in the descending order for an individual (which is a case) at marker m and
their corresponding weights. The weights are calculated by re-weighting these three
certainty rates to sum to 1 (shown in the right column in Table 3.3). Normally, if we
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don’t consider certainty rate (which will only consider the ancestral haplotype pair
with the highest certainty rate), then this individual contributes 1 to the counts of
case with 2 copies of haplotypes 1 at marker m. Now, if weighting by the re-weighted
certainty rates, this individual contributes p∗1 and p
∗
2 to the counts of case with 2
and 1 copies of the putative risk haplotype 1, respectively.
Table 3.3: Weighting the counts based on re-weighted
certainty rates

















We simulated disease status on this human dataset using the same disease model and
a similar simulation procedure as in section 3.4.2. We generated 100 datasets given
each of 48 scenarios —two disease models (GRR 1:2:4 and 1:3:3) and 24 causative
SNPs (eight in each of three DAF bands). Each dataset consists of 150 cases and
150 controls given a disease prevalence 12%. We removed the 24 causative SNPs,
as well as 216 SNPs in strong LD with any of them (r2 ≥ 0.8), when performing
ancestral haplotype inferences (note that here we only conduct one repetition of the
EM algorithm) and all association tests.
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The permutation procedure is the same as in section 3.4.2, but here we generated
1,000,000 permutation datasets for each scenario. From each permutation dataset,
we calculated the statistics for each marker from AncesHC and the single-SNP Ar-
mitage trend test. To assess the power for both methods, a target region is defined
as a region which covers 100kb each side of the causative SNP. As the block size
observed in the human dataset is small, to obtain a robust assessment, the target
region is defined as a region with a fixed length 200kb rather than the causative
block and its two flanking blocks which were used in the application to the mouse
dataset. We consider a true positive if the significant test statistics arise in this
target region. The minimum p-value over this 200kb region is calculated for both
methods.
3.5.3 Results
Figure 3.7 presents the power of AncesHC and the single-SNP test (the Armitage
trend test) with and without the incorporation of certainty rates and calling prob-
abilities as a function of significance level for the six combinations of disease model
and DAF band. In the comparison within the same testing method, AncesHC in-
corporating certainty rates has slightly greater power than without incorporating
certainty rates. Comparing between different test methods, AncesHC has greater
power than the single-SNP test for both disease models in two DAF bands (DAF
3–6% and 7–9%). For common variants (DAF 13–15%), AncesHC is slightly less
powerful than the single-SNP test in the dominant disease model (GRR 1:3:3) but
has comparable power with the single-SNP test for the additive disease model (GRR
1:2:4).





















































































































































































































































































































































































































































Single-SNP analyses are widely used in large scale genome-wide association studies
(WTCCC, 2007; Sladek et al., 2007). However, this approach is unable to capture
the effects of LD between neighbouring marker SNPs. We have presented AncesHC,
based on haplotype clustering using a HMM to predict shared ancestral haplotypes.
This approach overcomes the problems of unphased genotypes and occasional miss-
ing genotypes, haplotype diversity and block boundary definition that can limit the
performance of other haplotype analyses. AncesHC also does not assume a diploid
organism, and works with multi-allelic states.
Our clustering model does not require pre-defined blocks or a sliding window scheme
to define haplotype boundaries. Kimmel and Shamir (2005) and Scheet and Stephens
(2006) exploited similar models to infer missing genotypes and haplotypic phase;
Huang et al. (2007) applied a similar HMM to find haplotype blocks and to in-
vestigate association between haplotypes and quantitative traits. Here, we use the
ancestral haplotypes inferred by our HMM to investigate associations with disease
status.
We have applied AncesHC to a mouse dataset and developed a simulation scheme
to generate disease-status for this dataset under various scenarios. AncesHC greatly
outperforms the single-SNP analysis for both disease models in all three DAF bands.
By exploiting local SNP correlations, our method improves power for a given type
I error to better capture untyped variants. AncesHC also has greater power than
CLADHC in almost all scenarios. Instead of employing similarity scores to cluster
haplotypes, our method infers cluster membership by modelling the joint haplotype
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structure among individuals in the framework of HMM. This may be the reason that
our approach provides better inference of haplotypes clusters, and thus has greater
power than CLADHC.
In our clustering model, we maximized over four values (2,4,6, and 8) for the number
of distinct ancestral haplotypes. We found that this gave improved power over using
a fixed number of ancestral haplotypes. We assumed a single causal SNP in our
study. By testing each ancestral haplotype for disease association at a time, our
current method may have less power to detect multiple causal variants or a single
causal mutation which is carried by multiple ancestral haplotypes. One way to
extend AncesHC for testing multiple causal SNPs is to consider multiple ancestral
haplotypes as causal, and test them together against all other ancestral haplotypes.
With this extension, we expect that our method would also provide improved power
for detecting multiple variants comparing with the single-SNP test and CLADHC.
The mice underlying the data used for the simulation study are descended from eight
inbred strains crossed over 50 generations. An advantage of this dataset is that it
provided the possibility of comparing results from the model with inferred ancestral
haplotypes to one in which ancestral haplotypes are known, because the founders
were genotyped. Further, there is much recent interest in this type of data as a
means to identify quantitative trait loci (Valdar et al., 2006; Shifman et al., 2006).
Many datasets derived from outcrossed individuals descended from inbred ancestors
are becoming available, for example pure-bred dogs which have interbred to produce
cross-breds and mongrels (Lindblad-Toh et al., 2005), and a recombinant-inbred lines
dataset from an eight-ways cross by sibling mating (Broman, 2005; Peters et al.,
2007). AncesHC is particularly well suited to such datasets, as we have illustrated
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using the mouse data.
We also applied AncesHC to a human dataset from the WTCCC. The simulation
results showed that AncesHC has greater power than the single SNP analysis in
most simulation scenarios. By comparing the power in two applications (in the
mouse data and human data), we found that AncesHC has relatively greater power
for the mouse dataset than for the human dataset. However, we expect the power
of AncesHC from analysing human dataset should increase when exploiting higher
number of ancestral haplotypes.
Application of our method to a genome wide scan (such as WTCCC dataset) of
500,000 SNPs in 2000 individuals would currently require approximately 2,000 hours
per run for 8 ancestral haplotypes. Although computationally demanding, use of
AncesHC for such analysis is feasible with a multiprocessor computing cluster. For
example, one way to apply our method to a genome wide scale dataset is to partition
given SNP sequences into overlapping segments. AncesHC then can be conducted on
all segments. Many segments can be analysed at the same time with a multiprocessor
computing cluster and thus the total required time will be largely reduced.
3.7 Extension
In above sections, we employed the Armitage trend test to analyse inferred ances-
tral haplotype clusters, but it is possible to use other statistics. In this section,
we employed other two methods—a linear regression model and a likelihood-based
method, to test clusters for disease association, which are also available in AncesHC.
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The test can be conducted on the SNP level, or block-wise, which is described in
section 3.3.2.
3.7.1 Linear regression model
To deal with quantitative phenotypes, we consider a linear regression model. The
model can be expressed as Y = Xβ + , where Y denotes the dependent pheno-
type, β consists of an intercept (β0) and the fixed effect of ancestral haplotypes on
phenotype, and  is the residual error. The pairs of inferred ancestral haplotypes
are the independent variables coded in the X matrix. Here, we assume that the
haplotypic/allelic effect is additive. We consider two types of X matrices—with and
without incorporating uncertainty rates of inferred haplotypes.
X matrix
Without certainty rate. When the certainty rates of inferred haplotypes are
not taken into account, the elements of the X matrix are simply the number of
chromosomes for each individual at marker m in the putative high risk haplotype
cluster. The first column represents an intercept and the remaining columns are the
ancestral haplotype clusters included in the model. Figure 3.8 gives an example of
how we obtain the X matrix for the regression model.
With certainty rate (dosage model). Alternatively, we can incorporate the cer-
tainty rates of inferred haplotypes in the regression model. For each SNP, we obtain
the certainty rates of all possible pairs of inferred ancestral haplotypes, from which
the expected count of chromosomes in each ancestral haplotype is calculated. In
Figure 3.9, I demonstrate the way of computing this expected count. The certainty
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Figure 3.8: An illustration of how we code the X matrix from inferred ancestral
haplotypes without considering the certainty rate. Here we consider 8 ancestral
haplotypes (z = 8). The element in the matrix is the number of chromosomes for
each individual at marker m in a cluster. For instance, for the individual 1, the
number of chromosomes in the cluster 2 is 2 and the numbers in the other clusters
are an 0. The first column of matrix is the intercept and the following correspond
to clusters 1-8. For a simple regression model, the X matrix consists of the first
column and one of other 8 columns, corresponding to the intercept and one cluster.
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rate for a pair of ancestral haplotypes can be treated as a weight contributing to the
expected count of chromosomes in an ancestral haplotype. The X matrix is then
constructed according to these expected numbers of chromosomes in each inferred
ancestral haplotype.
Statistical tests and parameter estimation are conducted through the maximum
likelihood method described below.
Likelihood ratio test
Under the assumption of independent errors with N(0, σ2), the likelihood function
of the data given this regression model is
L(Φ|Y ) = (2piσ2)−n/2 exp(−(1/2σ2)
∑
(Y −Xβ)2) (3.1)
where n is the number individuals and Φ = (β, σ2) which are the fixed effect and
variance respectively. Here we obtain the maximum likelihood estimation (MLE)
for parameters β and σ2. To test the hypothesis of no association between cluster(s)
and phenotype the likelihood ratio test is used:
Λ = −2[log(L(Φ0|Y))− log(L(Φ|Y))] (3.2)
where Φ0 = (β0, σ
2
0) is the parameter set under the null hypothesis. We use the
simple regression model to test disease association one ancestral haplotype at a
time. Thus, the distribution of Λ is approximated by a χ21 for the simple regression
model.
In addition to using a χ2 approximation, we also calculate p-value of association
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 Inf erred an cestra l hap lo types with certa inty ra tes   
An exam ple dataset at m arker m , w ith  eigh t assum ed  ancest ral hap lotypes 
(clusters)  represen ted  by 1 ,2 ,… ,8 . Note we only l ist the cluster pairs w i th  
non  zero  certain ty  rate:  
 
Ind ividuals 
Inf erred  clusters 
( cer tain ty  rates) 
1  22 , 12 , 23 (0 .8 , 0.1 ,.0 .1 ) 
2  67, 66  
(0 .95 , 0 .05)  
3  
27  
( 1.0 ) 
4  
61 , 11 , 46 
(0 .9 , 0 .08 , 0 .02) 
: :  
: :  
 
 














1      0 .1     p      0 .1    0        0      0        0        0  
1      0        0      0       0        0      1 .05   0 .95  0  
1      0        1      0       0        0      0        1        0  
1      1 .06  0      0       0 .02   0      0 .92   0        0  
:      :         :      :        :        :       :       :        : 
p= 0.8 *2 +0 .1+ 0.1=1 .8  
Figure 3.9: An illustration of how we code the X matrix from inferred ancestral
haplotypes with the certainty rates. Here we consider 8 ancestral haplotypes (z = 8).
The element in the matrix is the expected number of chromosomes in a cluster
weighted by the certainty rates. For instance, for individual 1, the expected number
of chromosomes in the cluster 2 is p, which is the sum of chromosome copies weighted
by the corresponding certainty rates over all possible pairs which contain the cluster
2. That is, a chromosome copy in the cluster 2 contributes ‘1 multiplied by its
certainty rate’ instead of ‘1’ to the count. The first column of the matrix is the
intercept and the following columns correspond to the clusters 1-8. For a simple
regression model, the X matrix consists of the first column and one of other 8
columns, corresponding to the intercept and one cluster.
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score (Λ) for each marker/block (markerwise p-value) by permutation (a similar
permutation process described in section 3.4.2). We randomly permute the phe-
notypes among individuals and repeat the test above. For each permutation, the
maximum association score over all the ancestral haplotypes is recorded. The em-
pirical null distribution is then constructed from the maximum scores over many
permutations, from which the p-value can be calculated.
We also calculate the experimentwise p-value for each marker, which can be inter-
preted as the probability that any of testing SNPs show statistical significance of
association by chance. Again, the empirical null distribution is created by permut-
ing the phenotypes. For each permutation, the maximum association score over all
the clusters and all the markers along the sequence is recorded. The empirical null
distribution is then constructed by these maximum scores of many permutation,
from which the experimentwise p-value is calculated.
We here focus on quantitative phenotypes applied to a linear regression. However,
it can be extended to a case-control study by employing a logistic regression and a
study with multiple phenotype by employing a multivariate regression model. Also,
discrete or continuous covariates can be included in the model.
3.7.2 Use of Bayes factor in ancestral haplotype clustering
In this section, we propose an alternative approach—a likelihood based method—to
test disease association. Assume that we have n individuals with binary phenotypes
(case and control) Y = yi, i = 1, . . . , n. We fix a cluster as a putative high risk
cluster at a time and test disease association with each cluster. First, we construct
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a full likelihood based on the number of cases and controls with 0, 1, and 2 chro-
mosomes in a cluster. Denote (c0, c1, c2) as the number of cases with (0, 1, 2) copies
of chromosomes in a cluster; (δ0, δ1, δ2) as the probabilities that a individual is a
case with (0, 1, 2) copies of chromosomes in the high risk cluster. The complete data
likelihood (Waldron et al., 2006) is
P (Y|δ) = δc00 δc11 δc22 (1− δ0)n0−c0(1− δ1)n1−c1(1− δ2)n2−c2 (3.3)
Where (n0, n1, n2) are the total numbers of individuals with (0, 1, 2) chromosomes
in a cluster.
Some researchers might be interested in the parameter (δ0, δ1, δ2), and work on
the likelihood in equation 3.3 to infer these parameters. However, I here focus
on obtaining the posterior odds ratio in favor of the model under the alternative
hypothesis (H1) over the null hypothesis (H0). Thus, I obtain the marginal likelihood












2 (1− δ0)n0−c0(1− δ1)n1−c1(1− δ2)n2−c2dδ0dδ1dδ2
= B(c0 + 1, n0 − c0 + 1)B(c1 + 1, n1 − c1 + 1)B(c2 + 1, n2 − c2 + 1)
(3.4)
where B is the beta function. Hereafter I use this likelihood (3.4) to compute the
Bayes factor. One advantage of this model is that this general likelihood model
does not require any assumptions about the disease model. However, this likelihood
based model has less power for the additive disease model which is believed to be
hold in most cases.
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Under the null model H0 (no disease association with the investigated cluster), the
disease risk parameter, δ, should be the same for a case regardless of the number of





= B(c0 + c1 + c2 + 1, n− c0 − c1 − c2 + 1)
(3.5)





where B = p(Y|H1)
p(Y|H0) is defined as the Bayes factor (the posterior odds ratio). Thus,
the Bayes factor for each cluster at each marker/block can be calculated by the ratio
of equations (3.4) and (3.5). A maximum score is then taken over all the clusters to
represent the association signal of the position.
Chapter 4
Inference of Haplotypic Phase and
Missing Genotypes in Polyploids
4.1 Motivation and objectives
The power of haplotype-based methods for association studies, identification of re-
gions under selection, and ancestral inference, is well-established for diploid organ-
isms. For polyploids, however, the difficulty of determining phase has limited such
approaches. Polyploidy is common in plants and is also observed in animals. Partial
polyploidy is sometimes observed in humans (e.g. trisomy 21; Down’s syndrome),
and it arises more frequently in some human tissues. Local changes in ploidy, known
as copy number variations (CNV), arise throughout the genome. Here we apply our
model, implemented in the software polyHap, for the inference of haplotype phase
and missing observations from polyploid genotypes. PolyHap allows each individual
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to have a different ploidy, but ploidy cannot vary over the genomic region analysed.
It employs a HMM and a sampling algorithm to infer haplotypes jointly in multiple
individuals and to obtain a measure of uncertainty in its inferences.
In the simulation study, we combined real haplotype data to create artificial diploid,
triploid, and tetraploid genotypes, and used these to demonstrate that polyHap per-
forms well, in terms of both switch error rate in recovering phase and imputation
error rate for missing genotypes. To our knowledge, there is no comparable soft-
ware for phasing a large, densely genotyped region of chromosome from triploids
and tetraploids, while for diploids we found polyHap to be more accurate than fast-
Phase. I also compare the results of polyHap to SATlotyper on an experimentally
haplotyped tetraploid dataset of 12 SNPs, and show polyHap is more accurate.
PolyHap is designed for use with SNP genotype data where the marker order is
known, and it is applicable for whole genome data. With genetic or physical maps of
plant genomes becoming increasing available (including that of potato (Meyer et al.,
2005; Simko et al., 2006)), I believe that polyHap is very useful for the geneticists.
4.2 Introduction
4.2.1 Introduction to haplotype-based polyploid analyses
Haplotype analysis plays an important role in the mapping of disease genes where
it has been shown to be more powerful than single-marker analysis (Mailund et al.,
2006; Liu et al., 2007; Su et al., 2008a) and provides finer localisation of causative
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mutations (Waldron et al., 2006). Haplotype-based methods may also be used to in-
fer aspects of population history, such as the effects of positive selection (Bersaglieri
et al., 2004) and recombination events (Stumpf and McVean, 2003). Also, there
is currently much interest in kinship as a confounding factor in association map-
ping (Yu and Buckler, 2006; Yu et al., 2006) and kinship can be estimated more
accurately from phased than from unphased genotypes (Flury et al., 2007).
Polyploidy is common in plant species, for example potato (Solanum tuberosum,
4n) and sugar beet (Beta vulgaris, 2n, 3n, 4n), and also occurs in animals such
as goldfish (Carassius auratus, 4n). As these examples illustrate, tetraploidy (4n)
is most common (Comai, 2005) but other ploidy levels occur. Partial polyploidy
arises in humans, occasionally at the level of entire chromosomes (e.g. trisomy 21;
Down’s syndrome). Within-chromosome changes in ploidy, known as copy number
variations (CNV), occur frequently throughout the genome and span intervals up to
many Mb. Some human tissues (e.g. heart and liver) are known to frequently show
variable ploidy, as do cancer cells. Our focus here is on autopolyploid populations
such as tetraploid potato, in which chromosome sets are of the same type and have
the same origin. In contrast, for allopolyploids such as wheat, pairs of chromosomes
with distinct origins are analyzed as diploid data using markers that are specific to
each pair.
The study of linkage disequilibrium (LD) provides a basis both for mapping disease
genes and for the investigation of evolutionary history. Some LD-based studies
have been conducted in polyploid species (Raboin et al., 2008; Simko et al., 2006).
To overcome the problems of inferring phase, most of this work was conducted
on homozygous individuals from inbred populations. However, since the effects of
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inbreeding depression often prevent the achievement of widespread homozygosity,
this approach is often limited to small regions of chromosomes. It may also be
inappropriate to make generalisations about the evolution of an out-breeding species
using data from artificially created inbreds Flint-Garcia et al. (2003). Another way
to conduct LD association analyses in polyploids is to treat the polyploid genotypes
as diploids by grouping all heterozygotes into one class, which can generate biased
estimates. It is clear, therefore, that there is much information in polyploid genomes
which is currently hidden from us due to the lack of phased genotype data.
Experimental methods for determining haplotypic phase are available, but are pro-
hibitively expensive for large-scale studies (Ding and Cantor, 2003). Consequently
statistical inference of haplotypic phase has become a popular alternative. Many
haplotype inference methods with different ideas and statistical models have been
proposed for diploids and one for polyploids. In the following sections, I review some
of these approaches.
4.2.2 Haplotype inference methods for diploids
In Chapter 2, I reviewed several programs (HIT, HINT, fastPHASE) applying hidden
Markov models to infer haplotypic phase from diploid genotypes. In this section, I
focus on other approaches for haplotype inference.
Parsimony-based method
The idea of the parsimony approach is to minimize the total number of distinct
haplotypes inferred. Such an approach reflects the fact that the number of observed
distinct haplotypes in the region of LD is very much smaller than the number of all
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possible haplotypes (which is all the possible combinations of heterozygous sites on
the sequence). Clark (1990) proposed an algorithm which attempts to minimize the
number of haplotypes observed in the sample by trying to resolve the unphased geno-
types into a set of known haplotypes. The algorithm starts with a list of haplotypes
observed from the individuals with unambiguous haplotypic phase. Then, other in-
dividuals are screened for the haplotype which is matched with one of the haplotypes
in the list, and the complementary of the matched haplotype is added into the list,
until the haplotypic phases of all individuals are resolved or no matched haplotypes
are identified. Later, ‘find a minimum number of haplotypes that explains a given
set of genotypes’ is referred to as the pure parsimony problem. Gusfield (2003) used
the integer-linear-programming formulation to compute a solution that minimizes
the number of distinct haplotypes, equally solving the pure parsimony problem.
They suggested that pure parsimony approach is practical for the genotype data of
up to 30 markers and 50 individuals. More recently, Lynce (2006) solved this pure
parsimony problem based on the boolean Satisfiability (SAT).
Maximum-likelihood based method
A variety of maximum-likelihood (Excoffier and Slatkin, 1995; Hawley and Kidd,
1995) methods has been developed for diploid genotypes. The general idea of these
methods is to use an EM algorithm to find haplotype frequencies that maximise the
likelihood of haplotype frequencies on the multiloci genotypes given the assumption
of HWE. Haplotype reconstruction then can be achieved by choosing the most prob-
able haplotype assignment given the genotype data and the estimated population
haplotype frequencies. To deal with the local maximum of the likelihood, several
ways of setting initial parameter values are employed in these methods. A common
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applied algorithm is to use different starting points and take the estimate of haplo-
type frequency that gives the highest likelihood. In principle, this method can be
applied to any length of sequence. However, in practice, the number of haplotype
frequency parameters (for every possible haplotype in the sample) increases expo-
nentially with the number of heterozygous loci. This leads to the limitation of using
maximum-likelihood based method due to the increase of computational demanding.
To overcome this problem, Qin et al. (2002) combined the partition-ligation (PL)
algorithm with the EM algorithm to handle large number of loci.
Fallin and Schork (2000) further studied the properties of this approach. Their
results suggested that many factors may influence the accuracy of haplotype fre-
quency estimation, such as LD (the stronger average LD across the constituent loci,
the higher the accuracy) or allele frequency (the rarer allele, the lower accuracy).
Bayesian based method
In the Bayesian framework, the unknown haplotypes of each individual are treated
as random variables. To calculate the posterior probability of these unobserved hap-
lotypes given the observed genotypes, prior information (beliefs about the pattern of
haplotypes) and the likelihood (the information observed from data) are combined.
From this posterior distribution, haplotypes then can be inferred for each individual
by choosing the most likely haplotype configuration or sampling from the posterior
distribution. Based on this framework, many Bayesian haplotype reconstruction
methods have been developed with the employment of different prior distributions
and computational algorithms to approximate the posterior distribution. In this
section, I will briefly review two methods, implemented in the software PHASE
(Stephens et al., 2001; Stephens and Donnelly, 2003; Stephens and Scheet, 2005)
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and HAPLOTYPER(Niu et al., 2002).
PHASE used a Gibbs sampling algorithm to obtain an approximate sample from
the posterior distribution of haplotypes given the genotype data. The algorithm
starts with a list of initial haplotypes obtained by guessing, and repeatedly chooses
an individual at random, where the individual’s haplotypes are estimated under the
assumption that all other haplotypes are correctly phased. The idea is that unre-
solved haplotypes tend to be similar to the known haplotypes. They used a simple
Dirichlet prior and a more sophisticated prior which approximates the coalescent.
Their results showed that the algorithm using an approximate coalescent prior out-
performs that using a Dirichlet prior. The latter version of phase incorporated the
idea of partition-ligation’ (PL) (described in HAPLOTYPER) and considered re-
combination between markers by taking into account marker spacing and the decay
of LD with distance.
HAPLOTYPER employed a Dirichlet prior for haplotype frequencies and the Gibbs
sampling algorithm to sample from the posterior distribution. A partition-ligation
(PL) algorithm was used to deal with large datasets. In this algorithm, haplotypes
are first reconstructed within short regions of consecutive loci. Then, the estimated
haplotypes are combined to obtain estimates of haplotypes across the whole con-
sidered region. This computational trick allows HAPLOTYPER to analyse the
sequences with many loci.
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4.2.3 Haplotype inference methods for polyploids
SATlotyper
Neigenfind et al. (2008) developed SATlotyper to infer haplotypic phase in polyploids
by extending the pure parsimony based method for diploids (see above section).
They employed a SAT-based formulation to find a minimum number of distinct
haplotypes which resolve polyploid genotypes. The SAT-based algorithm considers
increasing sizes for a set of distinct haplotypes, from a lower bound 1 to an upper
bound 2n, where n is the number of individuals. The algorithm terminates when
every polyploid genotype is explained by a pair of haplotypes in the haplotype set
(Lynce and Marques-Silva, 2006), which is the most parsimonious (smallest) set of
explaining haplotypes.
Given a genotype, haplotype assignment from a pre-defined set of haplotypes is
expressed as a boolean formula in conjunctive normal form. The formula evaluates
to be true if a satisfying haplotype assignment can be found. The size of haplotype
set starts from 1 and each set is evaluated by the formula. A distinct haplotype
is added each time and SAT evaluation is conducted. The size of haplotype set
expands until the set is able to explain all the genotypes, where each genotype has
at least one satisfying haplotype assignment. This set solves the pure parsimony
problem for the given population.
However, as we mentioned in the previous section about the limitation of parsimony-
based methods, such approach is limited as it is not appropriate (and efficient) to
infer haplotypic phase over a region containing many markers.
Our method
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Here, we propose a HMM based method (polyHap) to infer haplotypic phase and
predict missing genotypes from polyploid genotype data. Our method employs a
polyploid HMM (see Chapter 2) to infer an ancestral cluster for each haplotype at
each marker, reflecting the idea that similar haplotypes are likely to have descended
from the same ancestral haplotype. The ancestral cluster allocations are highly cor-
related across tightly-linked loci, reflecting limited recombination since the common
ancestors. PolyHap first learns the ancestral clusters from genotype data jointly for
all individuals, then infers phased sets of ancestral clusters for each individual, and
hence infers the underlying haplotypes.
4.3 Method, material and simulation
4.3.1 Method
The main model is introduced in Chapter 2. Here I specify the priors used in this
application. The method is based on the polyploid HMM which has introduced in
Chapter 2. For the scalars u in the Dirichlet prior distribution, we used uθ = uα = 1
and uJ = 10
5 for initialisation of the EM algorithm and uθ = uα = uJ = 0.1 for
the maximisation step. The same as the previous chapter, we used 2, 4, 6, and 8
ancestral haplotypes. For the haplotype inference, we used the sampling algorithm
to infer haplotypic phase, which provides the certainty rate of each estimate.
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4.3.2 The data
Simulated dataset
We used the simulated datasets to assess the performance of polyHap. Here I de-
scribe how we used the data from the WTCCC to create phase-known polyploid
genotypes. Haplotype data were obtained from a 6.4 Mb non pseudo-autosomal re-
gion of the X-chromosome (34,135,863 to 40,527,829 bp) genotyped by the WTCCC.
We included 1464 males from both the 1958 British Birth Cohort and the UK Blood
Service Control Group, after removing eight males showing high levels of heterozy-
gosity. We then removed 243 SNPs on the whole X-chromosome which showed any
heterozygosity. We included all 501 sites analysed by the WTCCC, of which only
468 were polymorphic in our sample and 426 had minor allele frequency > 1%.
We randomly combined the X-chromosomes, first into pairs to create 500 diploid
genotypes, then into triples and then quadruples, to create 488 triploid and 300
tetraploid genotypes.
Experimentally haplotyped tetraploid dataset
We also applied our method on a experimentally haplotyped tetraploid dataset. The
dataset, described in Neigenfind et al. (2008), consists of experimentally determined
haplotypes at the BA213c14t7 locus with 12 SNP sites from 19 tetraploid individuals
(potato). In Neigenfind et al. (2008), 590 amplicon-derived clones were sequenced
over a 500 bp region, and 10 distinct haplotypes were identified among those 19
samples. The most probable genotype for each sample was then determined based
on the observed haplotypes and the frequency of each haplotype sequence (see detail
in Table 5 of Neigenfind et al. (2008)). We analysed these genotypes using polyHap
and SATlotyper, and assessed the performance of these two softwares by comparing
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Figure 4.1: Identifying a switch error in the triploid case. In general we require at
least N = 3 polymorphic sites to determine a phasing error. Here because we can
assume that the ordered haplotypes are correct up to and including marker m− 1,
we can see immediately (by comparing the true and inferred haplotypes) that there
is a switch at locus m between haplotypes 1 and 3.
the computed haplotypes with experimentally determined haplotypes.
4.3.3 Switch error rate
We used the switch error rate to examine the accuracy of haplotype estimates in
this application. The switch error rate for each individual is defined as ψ/(nh−1),
where nh denotes the number of heterozygous sites for that individual and ψ is the
minimal number of switches needed to recover the true haplotypes. We assume that
at most one switch could occur between consecutive heterozygous sites.
For each individual, we determined if there was a switch by comparing the inferred
haplotypes to the true haplotypes. If a discrepancy is identified at a heterozygous
marker m, a switch error is counted (e.g. Figure 4.1) and a switch is introduced in
the inferred haplotypes to ensure that it matches the true haplotypes up to marker
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m. To identify a discrepancy, it is only necessary to compare haplotype sets as far
back as to distinguish N distinct preceding haplotypes (N is the ploidy), which in
diploids requires looking back to the previous heterozygous marker only.
4.3.4 Assessment of r2
We evaluated methods (polyHap and fastPhase) of estimating the value of r2 (see
section 1.4) between a pair of SNPs. To assess the effect of phasing errors on
the resulting estimates, we compared r2 values calculated from inferred haplotypes
(estimated r2) with those from the simulated haplotypes (true r2).
In some polyploid studies (Simko et al., 2006), multiple sets of chromosomes have
been considered as diploid to measure LD, due to the limitations imposed by the
markers used and the lack of phase information. To assess the effect of this approx-
imation, we calculated r2 via fastPhase by analysing polyploid genotypes as if they
were diploid. For example, the tetraploid genotypes AAAB, AABB, and ABBB
are all regarded as AB, while AAAA and BBBB are represented as AA and BB
respectively.
4.4 Results
Due to limited availability of phase-known SNP data from polyploid species, we
evaluated the performance of polyHap by randomly combining human male X-
chromosome haplotypes from the WTCCC to create datasets of artificial diploid,
triploid and tetraploid genotypes. For diploids we compare with fastPhase which
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is a well established method and of comparable computational speed to polyHap.
For triploids and tetraploids, we attempted to compare with SATlotyper, but we
found that the scale of our simulated dataset was not computationally feasible for
SATlotyper. Note that we use the most likely haplotype assignment when calculat-
ing the imputation and switch error rates. To evaluate the imputation error rate,
1% of all genotypes chosen at random were set as missing, and we report in Table
4.1 the proportions of missing genotypes that were assigned incorrect genotypes for
polyHap and (diploids only) fastPhase. With eight ancestral haplotype clusters in
diploids, polyHap had an imputation error rate of 3.9% after one repetition of the
EM algorithm (see methods), falling to 3.8% after ten repetitions, compared with
5.0% and 4.6% for fastPhase. With 20 clusters, the error rate of 4.4% (4.3%) for
fastPhase with one (ten) repetitions remained higher than for polyHap with eight
clusters. For triploid data, polyHap’s error rate increased to 5.6% (4.7%), and for
tetraploid data it was 7.3% for one repetition (due to computational demands, only
one repetition was performed on the tetraploid dataset).
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Table 4.1: Imputation Error Rates
diploid triploid tetraploid
method I=1 I=10 I=1 I=10 I=1
polyHap:
z =8 0.039 0.038 0.056 0.047 0.073
z =6 0.040 0.045 0.058 0.060 0.087
z =4 0.049 0.044 0.077 0.065 0.106
z =2 0.101 0.085 0.144 0.114 0.194
fastPhase:
z =20 0.044 0.043
z =10 0.046 0.045
z =8 0.050 0.046
PolyHap also provides a measure of certainty between zero and one for each imputed
genotype. Figure 4.2 shows a histogram of the distribution of certainty scores, and
the average imputation error rate in each histogram bin, after running polyHap
with eight clusters and one repetition. For all ploidies, more than 80% of predicted
genotypes have certainty > 0.9, and the imputation error rates are < 1% in this
bin. More generally, the dashed curves in Figure 4.2 lie close to the line y =
1−x, indicating that our certainty score is approximately the probability that the
imputation is correct.
Average switch error rates are reported in Table 4.2. With eight ancestral haplo-
type clusters, polyHap had an error rate of 7.8% (6.8%) for one (ten) repetitions
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respectively, compared with 9.3% (7.8%) for fastPhase. With 20 clusters, fastPhase
had a switch error rate of 8.7% (7.1%), still greater than for polyHap with eight
clusters. For triploid data, polyHap’s error rate increased to 12.7% (11.4%) and for
tetraploid data, it was 17.5% for one repetition.
Table 4.2: Switch Error Rates
diploid triploid tetraploid
method I=1 I=10 I=1 I=10 I=1
polyHap:
z =8 0.078 0.068 0.127 0.114 0.175
z =6 0.085 0.074 0.132 0.117 0.239
z =4 0.098 0.082 0.147 0.127 0.263
z =2 0.153 0.119 0.241 0.186 0.323
fastPhase:
z =20 0.087 0.071
z =10 0.098 0.076
z =8 0.093 0.078
PolyHap also provides a certainty measure for the phase assignment. Figure 4.3
shows the distribution of certainties over ten bins, as well as the average switch error
rate in each bin for a run of polyHap with eight clusters and one repetition. For
all ploidies, there is a decreasing relationship between certainty of phase assignment
and switch error rate. For diploids, the certainties above 50% are well calibrated
with the switch error rate. Moreover, 80% of phase estimates have certainty > 0.9,
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Figure 4.2: Histogram of certainty scores and imputation error rate in each bin.
The histogram shows the distribution of certainty scores for imputations of missing
genotypes, when polyHap was run with eight ancestral clusters and one repetition
of the EM algorithm. The red circles indicate average imputation error rates within
each histogram bin.
and the switch error rate is < 1% in this bin. For triploids, ∼ 75% of phase estimates
have certainty > 0.7, and average switch error rate is < 6% in each of these bins.
For tetraploid data, ∼ 50% of phase estimates have certainty > 0.5, and the average
switch error rate is < 8% in each of these bins.
To assess the effect of haplotype inferences on inferences about LD, we compared
r2 values calculated from inferred haplotypes (estimated r2) with those from the
simulated haplotypes (true r2). Panels A-C of Figure 4.4 shows that r2 estimated
via polyHap is highly correlated with the true r2, even for tetraploids. Similarly in
Panel D, r2 estimated via fastPhase and the true r2 are highly correlated. Panels E
and F show that existing methods based on treating polyploid genotypes as diploid
lead to imprecise estimates of r2.
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Figure 4.3: Histogram of certainty scores and switch error rate in each bin. The
histogram shows the distribution of phasing certainty scores, averaged over individ-
uals, for the same polyHap runs as in Figure 4.2. The red circles indicate average
switch error rates within each histogram bin.
We also applied polyHap to a tetraploid potatos dataset (section 4.3.2) and com-
pared the results with those from SATlotyper. PolyHap had an average switch error
rate of 6.6% with eight ancestral haplotypes for ten repetitions, while SATlotyper
had error rate of 8.8%. Also, among 17 samples (excluding two samples having ho-
mozygous genotypes at all 12 sites), 15 samples were phased correctly for the whole
sequence by polyHap, compared with 13 samples by SATlotyper.
The computing time of polyHap with eight clusters and one repetition for a dataset
of 501 markers and 500 (488, 300) individuals for diploid (triploid, tetraploid) was
approximately 0.5 (4, 30) hours. The corresponding computing time for fastPhase
with 20 clusters and one repetition (only for diploid) was approximately 7 minutes.
Although fastPhase with one repetition was fast, the results were less precise than
those from polyHap. Attempting to run SATlotyper on the dataset of 501 markers
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on a 16GB computer (the same as was used to run polyHap). The problem persisted
when we reduced the number of markers to 50. Reducing it further to 25 markers
(still with 300 tetraploid individuals) allowed the program to run but it failed to
generate a result after 72 hours.
4.5 Discussion
In this Chapter, we present polyHap software for inferring haplotypes from poly-
ploid genotype data with some missing observations, using a HMM similar to that
underlying fastPhase Scheet and Stephens (2006) and HINT Kimmel and Shamir
(2005) for diploid data. As we mentioned in the previous Chapter, the optimal num-
ber of ancestral clusters is typically unknown. In this chapter, we have considered
2,4,6 and 8 clusters, finding in general that more clusters provides better inferences
but at increased computational cost. The same as AncesHc, polyHap does not re-
quire pre-defined haplotype blocks nor a sliding window scheme to define haplotype
boundaries. Although we focus on biallelic markers here, polyHap could be adapted
to allow for multi-allelic markers.
The results from the evaluation of polyHap are encouraging: using eight ancestral
clusters we obtained imputation error rates of 4.7% and 7.3%, and switch error
rates of 11% and 18%, for triploids and tetraploids respectively. For diploid data,
we obtained lower imputation and switch error rates for polyHap than for fastPhase.
Phasing using polyHap generated a considerable improvement in the estimation of
r2 from polyploid data over estimates based on treating polyploids as diploids. The
certainty values generated by polyHap are approximately well-calibrated as error
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probabilities for imputation of missing genotypes, and provide a useful guide to the
quality of phase inferences.
A difference between fastPHASE and our model is that our transition probability
between unordered lists of clusters is obtained by summing over permutations of the
to ancestral haplotype. As a consequence, in the case where N = 2 and l1 = l2 (see
equation 2.2) there is only one permutation of sm and hence only one term in the
sum. On the other hand, whenever N = 2 and l1 6= l2 there are two terms in the
sum, in contrast with other three models which has only one term when k1 = k2.
Our model ensures that the sum of probabilities of possible transitions between two
sites equals to 1. This may be the reason that our method provides more accurate
estimates than fastPHASE.
We have shown that polyHap outperforms SATlotyper on a tetraploid dataset which
was experimentally haplotyped. The switch error rates are 6.6% for polyHap com-
pared to 8.8% for SATlotyper and more samples are phased correctly by polyHap
(88%) than SATlotyper (76%). Although this potato dataset is small, the results
strongly suggest that polyHap is at least as good as SATlotyper for phasing a short
region. Moreover, polyHap is able to phase genotypes in a long region with many
SNPs whereas SATlotyper is limited to analysing a relatively small number of SNPs.
There are two features of polyHap, which are derived from the model described in
Chapter 2, allowing polyHap to exploit the flexible data structure. First, polyHap
supports datasets containing individuals of different ploidy, but not variable ploidy
within an individual. However, in the latter case separate runs of polyHap can be
applied over regions where within-individual ploidy is constant. In some situations,
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phased haplotypes are available for some individuals (e.g. from a study of inbreds
or other laboratory process). PolyHap can exploit the extra information about
haplotype structure from any available phased individuals; the resulting reduction
in error rates will vary depending on the sample size and other factors.
Second, in addition to imputing completely missing genotypes, polyHap also sup-
ports a scenario in which the genotype is partially known, for example at dominant
markers in which only the presence or absence of a particular allele is known. Our
model, incorporating this partial information from available alleles, is expected to
give better inference than the conventional approach which ignores the partially
available alleles and considers partially missing data as completely missing.
4.6 Conclusion
Knowledge of phase allows powerful haplotype-based methods to be exploited in
genetic analyses. The inference of phase in the diploid case is well established
and the advantages of inferred haplotypes are now widely appreciated. Polyploid
organisms present greater challenges and, until now, phase has been difficult to
determine routinely unless detailed pedigree information is available.
Using our polyHap software, the phased genotypes of triploid and tetraploid or-
ganisms can now be inferred from samples of unrelated individuals. Importantly,
the quality of the inferences can be measured and allowed for in subsequent analy-
ses. Thus the quality of subsequent inferences can be assessed, reducing the risk of
overconfident extrapolations from imperfect data.
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In terms of both switch and imputation error rates, polyHap was superior in our
simulation study to a well-established software for diploids, and offers good accuracy
at higher ploidy. As a demonstration of the utility of the approach, we show good
agreement in terms of LD (measured as r2) between inferred and true data.
With increasing marker densities and improving genetic and physical maps in many
polyploid species, together with increasing information about, and recognition of
the potential importance of, CNV regions in humans and other species, we believe
that polyHap will prove to be a timely addition to the geneticists toolkit.
4.7 Extension
In this section, I describe two extensions of polyHap to a trisomy dataset and a
DArT marker dataset. Previous results show that using 8 ancestral haplotypes in
the model gives the most accurate haplotype estimates (comparing with those from
using 6, 4, and 2 ancestral haplotype). Thus, we used 8 ancestral haplotypes as well
as 10 repetitions of the EM algorithm when running polyHap for both extensions.
4.7.1 Application to the trisomy data
We applied our method to a trisomy dataset provided by Anne Trewick at Imperial
College London, consisting of 16 SNPs in the region of 46,351,620-46,383,462 bp on
Chromosome 21. We included 148 trio families consisting of trisomy heart defect
children and diploid parents. This dataset contains 78 missing genotypes including
completely missing genotypes and partial missing genotypes. For this analysis, we
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considered all samples to be independent when inferring haplotypic phase. We then
assessed the performance of our method by comparing phased haplotypes in children
(considered as triploids) with phased haplotypes in parents (which are diploids).
Note that the phased haplotypes from diploid parents are considered to be true and
used to examine the phased haplotypes from triploid children. We calculated the
number of families in which the phased haplotype in the child is exactly matched
with one of those in the parental haplotypes within the analysed region (containing
16 SNPs).
In the results, we observed 97 (65%) families where the child’s haplotypes are
matched with the parental haplotypes. We could infer that there is no phasing
error or imputing error among these families. We also observed 37 (25%) fami-
lies where the phased haplotypes in the child have one marker unmatched with
the parental haplotypes. Apart from the phasing error and imputation error from
our program, this unmatched marker might also result from a recombination event
between chromosomes, mutation or genotyping error.
4.7.2 Application to DArT markers
SNPs have been commonly used in human and other species as markers. The cost
of genotyping these gel-based markers has decreased in recent years but it remains
economically prohibitive for many agricultural plants. Also, the SNP genotyping
system is dependent on sequence information. For some plant species, it might not
be practical to determine a large scale of genomic sequences, particularly when a
new allele is identified.
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Diversity Arrays Technology (DArT), a low cost and high throughput method, is a
hybridisation-based genotyping technology that is based on microarray platform to
identify and type DNA polymorphisms (Emma et al., 2008). We denote ‘DArT geno-
type’ by the genotype observed at a DArT marker (a biallelic, dominant marker).
The DArT genotype is either 0 referring to the homozygous recessive genotype (BB)
or 1 to the heterozygous or homozygous dominant genotype (AB or AA), assuming
that A and B represent the dominant and recessive allele respectively. Since identify-
ing polymorphic DArT marker does not require the information of DNA sequences,
this technology is applicable to all species. However, the DArT genotype provides
less information of polymorphism because both the heterozygous and homozygous
dominant genotypes are coded as 1 at DArT markers. Here, we apply polyHap to
identify the heterozygous and homozygous dominant genotype. We focus on pre-
dicting heterozygous and homozygous genotypes from DArT marker. We expect
that the performance of haplotypic phase inference is similar to the case of diploid
genotypes (see Section 4.4).
Simulation
We investigated the performance of polyHap for predicting the heterozygous and
homozygous genotype at DArT markers with the simulated datasets. First, we ob-
tained diploid genotypes by randomly pairing the X chromosomes from the WTCCC
datasets (detail described in section 4.3.2). To create the DArT genotypes in the
dataset, we convert some of these diploid genotypes to the DArT genotypes at dom-
inant markers (which is the site having at least one dominant allele). In this thesis,
we assume that the minor allele is the dominant allele. In each simulated dataset, a
proportion of dominant sites were selected to set as DArT markers. First, we con-
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sider all (100% of) the dominant sites to be DArT markers. In this case, all of the
heterozygous or homozygous dominant genotypes are converted to DArT genotypes.
In our program, the DArT genotypes are considered as the missing genotypes with
the prior probabilities for the frequency of heterozygous and homozygous dominant
genotypes.
We also select different proportions of dominant sites to be DArT markers. To
provide a comprehensive investigation, we consider three different ascertainment
schemes for selecting DArT markers in the simulated datasets. First, we consider
the scenario that individuals are genotyped on different platforms—some individu-
als are genotyped with the DArT chips while others are genotyped with the SNP
chips. Given this scenario, we selected 50%, 70%, and 90% of individuals in the
simulated dataset, where the genotypes at the dominant sites of these selected indi-
viduals are all converted to DArT markers (the ascertainment scheme 1). Note that
the genotypes at unselected dominant sites (or from unselected individuals) remain
unchanged in the simulated dataset.
However, such a scenario is not always the case in the study. We also consider the
situation where some loci on the chromosomes are genotyped with DArT probes
while others are genotyped with non-DArT probes, which might be due to the
availability of the probes at the specific locus. To simulate this scenario, we randomly
select 50%, 70%, and 90% of SNPs in the simulated dataset respectively, where the
selected SNPs are considered as DArT markers across all individuals, where the
genotypes at unselected sites remain unchanged (the ascertainment scheme 2).
The third situation we consider is that DArT markers are randomly selected from the
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dominant sites over all SNPs and individuals according to three different percentages:
50%, 70%, and 90% (the ascertainment scheme 3). We can consider the data in
the form of a two-way matrix, where individuals are represented by rows of the
matrix and SNPs are represented by columns of the matrix. We randomly select a
percentage of rows in the ascertainment scheme 1 and a percentage of columns in
the ascertainment scheme 2. For the ascertainment scheme 3, a percentage of cells
(at the dominant sites) in the matrix are chosen randomly to be DArT markers.
The prior
In the program, the frequency of heterozygous and homozygous dominant genotypes
at a DArT marker can be estimated by the allele frequency under HWE. Thus,
in the EM training process(see section 2.4), we give a prior distribution to the
frequencies of heterozygous and homozygous dominant genotypes at DArT markers.
The frequency of the recessive allele, q, of each SNP can be calculated from the
data. The frequency of the dominant allele, p, is then obtained by 1 − q. Under
the assumption of HWE, the prior probabilities for the frequencies of heterozygous
and homozygous dominant genotypes are given by 2pq/(2pq+ q2) and q2/(2pq+ q2)
respectively when running polyHap. Other priors are the same as described in
section 4.3.
Results
Table 4.3 reports the prediction error rates which is the percentage of incorrectly
predicted heterozygous and homozygous genotypes among assumed DArT markers.
For the dataset with 100% of DArT markers, polyHap gives an error rate of 0.172.
PolyHap provides more accurate estimates when DArT markers are selected ran-
domly over the SNPs and individuals (ascertainment scheme 3), which gives error
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rates of 0.075, 0.116 and 0.159 for the datasets with 50%, 70% and 90% of DArT
markers. For the ascertainment schemes 1 and 2, PolyHap gives similar prediction
error rates in the range of 0.140-0.171 for the datasets with 50%, 70% and 90% of
DArT markers.
Table 4.3: Error rates of predicted heterozygous and ho-
mozygous genotypes
Percentage of DArT markers
Ascertainment scheme 50% 70% 90% 100%
1 0.159 0.164 0.171 0.172
2 0.140 0.161 0.171 0.172
3 0.075 0.116 0.159 0.172
Figure 4.5 gives the distribution of certainty rates, and the average prediction error
rate in each bin of certainty scores. (A)-(C) represent the results from analysing
datasets with DArT markers generated by the ascertainment schemes 1-3, respec-
tively. For all datasets, more than 89% of the predicted heterozygous and homozy-
gous genotypes have the certainty rate > 0.9, and the prediction error rates are
< 15.2% in this bin.
4.7.3 Discussion
In this section, I present two applications of polyHap to the trisomy dataset and
the DArT dataset. Our preliminary results from analysing these datasets show
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Figure 4.5: Histogram of certainty scores and prediction error rate in each bin. The
histogram shows the distribution of certainty rates for the predicted heterozygous
and homozygous dominant genotypes at DArT markers, when polyHap was run
with eight ancestral clusters and ten repetitions of the EM algorithm. The red
circles indicate average prediction error rates within each histogram bin. Rows
(A)-(C) represent the results from the datasets simulated from the ascertainment
schemes 1-3, respectively. Each column shows the results from analysing different
percentages of DArT markers in the dataset.
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that polyHap provide accurate estimates of inferring haplotypic phase from trisomic
genotypes and good prediction of heterozygous and homozygous dominant genotypes
from DArT markers.
In the application of the trisomy data, we used the information from the trio families
to assess the performance of polyHap because the true haplotypic phase is unknown
in this dataset. This might not be able to provide an efficient assessment. However,
the trisomy genotypes can be considered as triploids and we have shown (in the pre-
vious sections of this Chapter) that polyHap performs well for inferring haplotypic
phase from triploid genotypes in term of the switch error rate. On the other hand,
it is useful to distinguish whether the trisomies are resulted from nondisjunction in
meiosis I or II (detailed in Chapter 6). We will discuss this extension in the Chapter
of the future work.
In the application of the DArT data, since we assume that the minor allele is the
dominant allele, the majority of genotypes at dominant sites are heterozygous under
HWE, which is approximately 82.6% of heterozygous genotypes among the dominant
sites in our datasets. Thus, the percentage of incorrectly predicted heterozygous and
homozygous genotypes at the dominant sites is 17.4% if we assign all the genotypes at
the DArT markers as heterozygous genotypes. This heterozygous assignment seems
as good as polyHap when the proportion of DArT markers in dataset is above 70%.
However, the advantage of this heterozygous assignment will dilute once the number
of heterozygous genotypes among the dominant sites decreases, which is one of the
avenues we are going to explore in the future.
Chapter 5
Joint CNV/SNP Haplotype and
Missing Data Inference
5.1 Motivation and objectives
With the increasing rate of discovery of copy number variation (CNV) throughout
the human genome and its potential impact on human diversity and complex dis-
eases, there is growing interest in investigating CNVs associated with diseases and
evolutionary history. Haplotype information is useful for these investigations. Many
methods are proposed to infer copy numbers and CNV genotypes, but very few are
designed for inferring CNV haplotypic phase. Here, we present a method for imput-
ing missing CNV genotypes, predicting allele configurations on a pair of haplotypes
and inferring CNV haplotypic phase from both CNV and non-CNV genotypes in
a large-scale population-based study. Our method, implemented in the software
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cnvHap, is based on a hidden Markov model, which models the joint haplotype
structure between CNVs and SNPs. Thus, haplotypic phase of CNVs and SNPs are
inferred simultaneously. A sampling algorithm is employed to obtain a measure of
confidence/credibility of each estimate. Our approach is flexible, allowing the copy
number (ploidy) to vary along the investigated sequence and across the individuals.
In order to investigate the effectiveness of our approach, we took genotype data
on genotyped male X chromosomes as well as known CNV regions on these sam-
ples (from array CGH) and randomly paired these into phased diploid and triploid
CNV/SNP haplotypes. We then investigated how well we could reconstruct the
phase of this data as well as infer missing CNV genotypes. The results of the sim-
ulation study suggest that our method provides accurate estimates of missing CNV
genotypes, allelic configuration, and CNV haplotypic phase.
5.2 Introduction
Copy number variations (CNVs) are pervasive in the human genome Redon et al.
(2006); Feuk et al. (2006) and could play a key role in human diversity and disease
susceptibility McCarroll and Altshuler (2007). Novel experimental technologies en-
able researchers to conduct genome-wide investigations of CNVs in high resolution.
The microarray Comparative Genomic Hybridization (array-CGH) technique pro-
vides a CNV resolution of tens of kilobases Iafrate et al. (2004); Sebat et al. (2004).
Various algorithms are proposed to detect CNV regions and to estimate the number
of copies in each region using the data from array-CGH platforms which consist
of logarithm intensity ratios between test and reference samples Lai et al. (2005);
5.2 Introduction 109
Fiegler et al. (2006). Recently, analysing the data from SNP arrays has become a
popular approach to investigating CNVs in the human genome. Many algorithms
are proposed for detecting CNVs from Illumina SNP arrays using the log R ratio
(LRR, the log ratio of observed to expected fluorescent signal intensity) and the
B allele frequency (BAF), such as CNVPartition Olshen et al. (2004), QuantiSNP
Colella et al. (2007), and PennCNV Wang et al. (2007), and from Affymatrix SNP
arrays using allele intensities directly, such as Birdsuite Korn et al. (2008). These
SNP-based approaches, exploiting SNP and copy number information simultane-
ously, provide high-resolution and efficient detection of CNVs.
With the progress of these CNV detection methods, many datasets containing CNV
regions, copy numbers and CNV genotypes are available Iafrate et al. (2004). How-
ever, alleles configuration or haplotypes are not determined in most of these datasets.
Current CNV association studies are conducted on the basis of CNV genotypes and
copy numbers Barnes et al. (2008); Korn et al. (2008). Owing to the difficulty of
obtaining haplotype information experimentally and the lack of efficient haplotypic
phasing programs for CNV genotypes, haplotype-based approaches, which have been
shown to be more powerful than single-marker analyses Mailund et al. (2006); Liu
et al. (2007); Su et al. (2008a), are not fully exploited in CNV association stud-
ies. Apart from association studies, the CNV haplotype information is also useful
for studying evolutionary history and facilitates the study of linkage disequilibrium
between CNVs and nearby SNPs.
The methods for inferring haplotypic phase from diploid genotypes are well de-
veloped and provide accurate inference of haplotypic phase Stephens and Scheet
(2005); Kimmel and Shamir (2005); Scheet and Stephens (2006); Su et al. (2008a).
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For polyploid organisms, two phasing programs, SATlotyper Neigenfind et al. (2008)
and polyHap Su et al. (2008b), are proposed and polyHap can be used for phasing
CNV regions which have the same ploidy for the investigated genomic region (but
ploidy can change across the individuals), where CNV genotypes are considered as
polyploids.
In this chapter, we describe an algorithm for CNV haplotype inference from geno-
types that extends the model described in Chapter 2, to take account of the joint
haplotype structure among individuals and to capture the changes of copy number
state. Our method, based on a HMM, allows the data to have different ploidies
along the sequence and across the individuals. In order to properly define what is
meant by CNV haplotyping, we consider the cases of deletion, proximal and dis-
tal duplication occurring in the genome as illustrated in Figure 5.1. In the case of
deletion and proximal duplication events which are transmitted in the population,
we observe that linkage disequilibrium (LD) can build up between flanking SNPs
and copy number state itself. Exploiting this LD pattern to infer which chromo-
some copy containing the CNV is called ‘non-internal phasing’ in our study. On
the other hand, for both proximal and distal duplication events, we observe that
the duplicated allele is usually the same as the original allele. However, this may
not always be true when the duplication was old (mutation might occur over gen-
erations) and/or the duplication process is imperfect. Thus, there is uncertainty
about haplotypic phase between the original and duplicated alleles. We define the
process of inferring haplotypic phase within the duplications as ‘internal phasing’,
which exploit LD within duplication relative to original unduplicated sequence.





























































































































































































































































































































































































































































































































































































































































































































































































































































































































































































Figure 5.2: Illustration of non-internal and internal phasing with a deletion and
a single copy of amplification. Non-internal phasing considers the genotypes as
diploids and treats the duplication and deletion as extra different alleles, whereas,
internal phasing considers the genotypes as triploids and introduces an extra chro-
mosome copy. This chromosome will accommodate the extra copy in the duplicated
region and will otherwise be set to a deletion state. Here, N is the ploidy..
internal phasing is to infer haplotypic phase of diploid chromosomes but not the
phase within duplicated alleles, where the genotypes are phased as diploids. For this
case, we allow different transition rates between copy numbers in our model. For
internal phasing, we focus on the inference of haplotypic phase locally for duplicated
alleles and thus genotypes are treated as polyploids. A recently proposed non-
internal phasing program for CNV haplotypic inference, CNVphaser, employed an
EM and partition-ligation (PL) algorithms to infer haplotypic phase given identified
CNV regions and copy numbers Kato et al. (2008).
The results show that our method provides accurate estimates of missing CNV
genotypes, allelic configuration on a pair of haplotypes (such as AA/B or A/AB),
and haplotypic phase in both levels (non-internal and internal phasing).
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5.3 Method
The method based on a HMM was introduced in Chapter 2. For internal phasing,
the model is similar to that in Chapter 4, except that the set of possible alleles is
{-, A, B}, which are a deletion, an A allele and a B allele. Here, we describe some
modifications made specifically for non-internal phasing.
Emission probability
In our method, each allele is assumed to be descended from one of z ancestral hap-
lotypes, which are the hidden states (haplotype states) in the HMM. The program
first learns the ancestral haplotype structure from genotypes jointly for all individu-
als. Based on this structure, allelic configuration, missing CNV genotypes and CNV
haplotypic phase are then inferred. This relationship between the allele and the
haplotype hidden state is modelled by the emission probability. In this study, we
allow a deletion and a single copy of amplification. Thus, the set of possible alleles
is {-, A, B, AA, AB, BB} underlying a diploid model.
For non-internal phasing, the allele configuration of a pair of haplotypes, in most
situations, can not be determined directly from a CNV genotype, such as a genotype
AAB (there are two possible allele configurations: AB/A or AA/B). We exclude the
situation where a deletion and a duplication occur at the same site, which is rarely
observed on human chromosomes. For these genotypes, we set θmln(h) in equation
(2.4) to be uniform over all possible allele configurations on a pair of haplotypes.




We introduce the extension of the transition model described in Chapter 2 by con-
sidering the transitions between the copy numbers and between the haplotypes. In
this extension, a given haplotype hidden state has a fixed copy number and there
can be multiple haplotype states underlying each copy number. In this study, we use
eight ancestral haplotype states for internal phasing and nine haplotype states for
non-internal phasing of which one haplotype state has the underlying copy number 0
(deletion), four haplotype states have the underlying copy number 1 (normal copy),
and four haplotype states have the underlying copy number 2 (a single copy of am-
plification). Note that the copy number states are the super states which categorise
haplotype states according to their underlying copy numbers.
We allow different transition models for the transition between copy number states,
for the transition between haplotype states which have the same copy number state,
and for the transition between haplotype states which have different copy number
states. To incorporate the copy number state in the transition model, here we
introduce a hierarchy transition model—the first transition level is the transition
between the copy number states and the second is between the haplotype states
given the copy number states (Figure 5.3). The idea of using this model is to capture
the favoured transition between the copy numbers. The transition probability from
haplotype state kn to ln is then the product of the transition probability between
copy number states and the transition probability between haplotype states given
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Figure 5.3: Illustration of two levels of the transitions based on the haploid model.
Each box represents the copy number state and the numbers in the box are the
assigned haplotype states. The first level of the transition (which is between the
copy number states) can be considered as the transition between the boxes. The
black dashed and solid lines give an example of the possible transitions from copy
number state 0 (the solid line represents the most likely transition). The second
level of transition (which is between the haplotype states) can be considered as the
the transition between the numbers given the boxes. The red dashed lines give an
example of the transitions from the haplotype state 1 to the haplotype states 3, 4
and 5 given that the transition between copy number states is from 0 to 1. Note
that the number of haplotype states in each copy number state can be specified by
users in our program.
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the copy number states:
p(smn = ln|s(m−1)n = kn) =
p(c(smn) = c(ln)|c(s(m−1)n) = c(kn))× p(ci(smn) = ci(ln)|ci(s(m−1)n) = ci(kn))
(5.1)
where c(ln) and c(kn) are the underlying copy number state for haplotype states ln
and kn respectively; and ci(ln) and ci(kn) are the indices of haplotype states ln and
kn within the copy number states c(ln) and c(kn). Both transition probabilities (the
two terms of the product in the equation) are calculated based on the equation (2.1)
with different parameters.
In this modification, we allow that the parameters Jm depends on the kn (‘from’)
state, denoted as Jmkn and αm is related to both the kn and ln (‘from’ and ‘to’)
states, denoted as αmknln . In order to capture linkage disequilibrium between SNPs
and CNVs, we use equation (2.1) with parameters Jmkn and αmknln to compute the
transition probability between copy number states and between haplotype states
given the transition occurring in different copy number states. We use the basic
transition model (the parameter Jm is independent of the state and αmln only de-
pends on the ln state) to calculate the transition probability between the haplotype
states given the same copy number state.
The prior and computation
We use Dirichlet priors on all of our parameters. We let θml ∼ Dirichlet(uθmθ),
where mθ is the uniform vector with each element equal to 1/H, and αm. ∼
Dirichlet(uαmα) where mα is the uniform vector with each element equal to 1/z.
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Also we let αCNmkn. ∼ Dirichlet(uαm
CN
αkn
) for the transition between copy number
states where mCNαkn is the uniform vector with each element equal to 1/nc (nc is the
number of copy number states); and αHSmkn. ∼ Dirichlet(uαm
HS
αkn
) for the transition
between copy number states where mHSαkn is the uniform vector with each element
equal to 1/ns (ns is the number of haplotype states within the copy number state);
We let Jm ∼ Beta(uJ(1−e−dmr), uJe−dmr) where dm is the physical distance between
consecutive markers and r = 10−8 per based pair in the population, reflecting the
background recombination rate. We use uθ = uα = 1 and uJ = 10
5 for initialisation
of the EM algorithm and uθ = uα = uJ = 0.1 for the maximisation step. In this ap-
plication, we conduct 10 repetitions of the EM algorithm with different start values,
where each repetition contains 25 iterations in the training process.
After obtaining the estimates of parameters at each repetition, a fixed number of
haplotypes are sampled from the posterior distribution conditional on the genotype
data of a given individual (see section 2.4). The most likely haplotypes with the
certainty rates are then inferred from all the sampled haplotypes across 10 repetitions
of the EM algorithm.
5.4 Material and Simulation
In this section, we present the details of the simulation study to evaluate the perfor-
mance of our method for inferring allele configurations, CNV haplotypes and missing
genotypes. We simulated phase-known datasets based on the data obtained from
French and Finnish population cohorts respectively with different technologies for
obtaining the copy number status and using different genotyping chips. The French
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dataset contains fewer samples but denser genotypes while the Finnish dataset con-
tains more samples but less dense genotypes.
The French samples
We obtained data for X chromosomes from 48 males of northern French origin who
were genotyped both on the Illumina 1M platform and 244k array Comparative Ge-
nomic Hybridization (aCGH) platform. The 244k aCGH chips provide information
on the locations of CNV regions as well as copy numbers in these regions across the
entire genome. In aCGH, test and reference DNA samples, which are labeled dif-
ferentially with fluorescent tags, are simultaneously hybridized into genomic arrays.
The fluorescent ratio of test and reference hybridization signal is then determined at
different positions along the genome, which provides information on the difference
in copy numbers between test and reference samples.
Here, CNV regions in the dataset from 244k aCGH chips were identified using the
ADM2 algorithm developed by Agilent Technologies (Santa Clara, CA, USA), which
recursively searches for CNV intervals based on log R ratios (LRR) of fluorescent
signals from probes between test and reference DNA samples (for more details, see
de Smith et al. (2007)). The boundary and size of a CNV interval are defined on
the basis of the positions of the first and last array probes in the interval.
We first identified CNV regions with high density aCGH probes on a 2.7 Mb non
pseudo-autosomal region of the X-chromosome (151,801,138 to 154,499,338 bp based
on NCBI build 35) on the 1M dataset from the 244k aCGH predictions. This region
has 1904 aCGH probes (equally 1 probe for every 1.4 kb) and 1106 Illumina probes.
In order to identify deletions and duplications in these regions, we use a simple
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threshold of LRR, where duplications are identified if LRR > -0.5 and deletions if
LRR 5 -0.5. This threshold is obtained based on that the reference DNA has two
copies, which is the female cell line in HapMap. As these regions were identified as
having duplications or deletions, we excluded the normal copy number (which is 1
on the non pseudo-autosomal region of the male X chromosome) when inferring copy
numbers. The CNV genotypes were then inferred based on the B allele frequency
from Illumina 1M chips. Note that the genotypes observed in non-CNV regions were
also obtained from the chips. We analysed all 1106 markers including non-CNV and
CNV sites on each individual reported by the Illumina 1M probeset.
The Finnish samples
We also assessed our method using a larger dataset from the Northern Finland Birth
Cohort (NFBC), which contains genome-wide genotypes on 695 Finnish individuals
assayed on Illumina Hap370 chips. CNV regions and genotypes are first predicted on
the X chromosome by cnvHap (developed by Lachlan Coin, Imperial College) which
infers copy numbers and CNV genotypes according to the B-allele frequency and the
log R intensity ratio based on the HMM. cnvHap, modelling SNP and CNV jointly
at the haplotype level, provides high-resolution and accurate CNV genotype predic-
tions. We analysed a 20.9 Mb region on the X chromosome (19502220 to 40491848
bp based on NCBI build 36) which contains 2149 markers on each individual.
The simulation of phase known genotypes
After having SNP and CNV genotypes ready on the X chromosomes, we randomly
combined these X chromosomes into pairs to create diploid genotypes for non-
internal phasing (Figure 2). We created 24 diploid genotypes in the French dataset
and 347 diploid genotypes in the Finnish dataset.
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To assess the performance of our internal phasing, it is easier to test it on the data
with genotypes up to one copy amplification at the genotype level, which can be
considered as triploids. When preparing the dataset, we identified deletions but not
duplications on the X chromosomes in the French and Finnish datasets because the
duplicated alleles are simulated by including an additional X chromosome (Figure
2). To create a dataset with the information of known internal haplotypic phase, we
combined the X chromosomes into triples to create 15 and 231 triploid genotypes in
the French and Finnish datasets respectively.
5.5 Results
Missing data imputation
We first examined the accuracy of our method for missing data imputation with
both French and Finnish data. In each dataset, 5% and 10% of genotypes with 1,2,3
and 4 copies of alleles were set as missing at random respectively. For the missing
genotypes, we assume the copy number is known. We report the proportion of
missing genotypes for each copy number that were estimated incorrectly (imputation
error rate). Table 5.1 show the imputation error rate in the French and Finnish
datasets respectively. Overall, our method provides accurate estimates of missing
genotypes. For both missing rates (5% and 10%), our method gives the imputation
error rate less than 0.09.
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Table 5.1: Error rate for estimation of missing
genotype
Copy number of genotype
Missing rate 1 2 3 4
French dataset
5% 0.020 0.034 0.060 0.0
10% 0.009 0.030 0.090 0.0
Finnish dataset
5% 0.062 0.075 0.053 0.028
10% 0.050 0.081 0.050 0.027
Allelic configuration inference
We assess the performance of our method for inferring allelic configuration on a pair
of haplotypes (such as AA/B or A/AB). Table 5.2 presents the distribution of copy
numbers observed on all markers and the error rate of estimated allele configurations
in the French dataset. 1155 genotypes have one copy of allele (deletion). For the du-
plication, 6317 and 754 genotypes have 3 and 4 copies of alleles, of which 1075 and 94
are heterozygous respectively. As the possible allele configurations (corresponding
to the observed genotypes) for heterozygous genotypes with 3 and 4 copies of alleles
may be more than one, our program provides estimates of allele configurations at
these sites. The error rate is the proportion of ambiguous genotypes where the al-
lele configurations are not correctly inferred. Here the ambiguous genotypes are the
heterozygous genotypes with 3 and 4 copies of alleles, which excludes the genotypes
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AAAB (and ABBB) because these genotypes only have one possible allelic configu-
ration AA/AB (and AB/BB). The error rates of estimation of allele configurations
are 0.119 and 0.0 for genotypes with 3 and 4 copies of alleles, respectively. For one
and two copies of alleles, there is only one possible allele configuration on a pair of
haplotypes.
Table 5.2: The distribution of copy number and error rate of estimation of allele
configuration at heterozygous sites
Copy number of genotype
1 2 3 4
French dataset
Distribution of copy numbers 1155 18318 6317 754
Distribution of heterozygous genotypes 0 2932 1075 94
Error rate of estimation of allele configuration NA NA 0.119 0.0
Finnish dataset
Distribution of copy numbers 5609 664847 60010 15237
Distribution of heterozygous genotypes 0 210239 24106 1572
Error rate of estimation of allele configuration NA NA 0.016 0.188
The results from analysing the Finnish data (in Table 5.2) give the prediction error
rate of 0.016 and 0.188 for the genotypes with 3 and 4 copies of alleles respectively.
There are 60010 and 15237 genotypes having 3 and 4 copies of alleles, of which 24106
and 1572 are heterozygous respectively.
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Inference of haplotypic phase of copy number state relative to flanking
SNPs (non-internal phasing)
For non-internal phasing we do not distinguish the order of alleles on the CNV
haplotype. We excluded the sites where allele configurations are incorrectly inferred
when calculating the switch error rate. The homozygous genotype with 3 copies of
alleles (A/AA or B/BB) are considered as heterozygous sites while the homozygous
genotypes with 4 alleles (AA/AA or BB/BB) are considered as homozygous sites.
Here, we assess the performance of our method for haplotypic phase inference using
switch error rate. For the French data, the overall switch error rate is 0.015. We
further calculated error rates over the pairs of copy numbers at heterozygous sites
given in Table 5.3. We first obtained the counts of pairs of consecutive heterozygous
sites where copy numbers change from N1 to N2 (denoted by N1 → N2), shown in the
parentheses in the table, where N1 = {1, 2, 3, 4} and N2 = {1, 2, 3, 4}. The switch
error rate of copy numbers N1 → N2 is the proportion of pairs of heterozygous sites
with copy numbers from N1 to N2 that are not correctly phased.
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Table 5.3: Switch error rate for non-internal phasing
CN on the second site (N2)
CN on the first site (N1) 1 2 3 4
French dataset
1 0.0009 0.26 0.571 NA
(1062) (15) (7) (0)
2 0.2 0.036 0.413 0.0
(15) (2866) (29) (1)
3 0.333 0.322 0.0008 0.0
(6) (31) (6150) (2)
4 NA NA 0 0.057
(0) (0) (3) (87)
Finnish dataset
1 0.067 0.360 0.396 0.142
(1373) (3022) (232) (7)
2 0.383 0.071 0.264 0.386
(2810) (204467) (2551) (101)
3 0.282 0.158 0.001 0.188
(436) (2163) (56688) (303)
4 0.333 0.235 0.357 0.076
(9) (289) (112) (286)
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Overall, the switch error rates are less than 0.34, apart from two cases where the
error rates are 0.57 and 0.41 at heterozygous sites with copy numbers 1 → 3 and
2 → 3 respectively. We observed that the number of observations at these sites
(i.e. at the position where the number of copies changes) is small. Also, each
individual could have different CNV regions along the chromosome. Thus, some
CNV haplotypes can be very rare. This could be the reason for the less accurate
estimates at these positions.
The results from analysing the Finnish Dataset are given in Table 5.3. For these
data, the overall switch error rate is 0.067. The error rate of each pair of copy
numbers at heterozygous sites, is less then 0.4. Again, the high error rate in some
cases might result from the rare haplotypes.
We further investigate the certainty rate of each estimate from the Finnish dataset.
Figure 5.4 gives the distribution of certainty scores, and the average switch error rate
in each bin of certainty scores. In general, the estimate with the higher certainty
rate provides the more reliable inference. However, we observed the low proportion
of estimates which have the high certainty rate (> 0.9) in some cases, such as copy
numbers 4→ 3.
To compare the results with those from CNVphaser, we chose three and eight sites
in two different CNV regions from the French data. The maximum number of CNV
sites used in the original CNVphaser article Kato et al. (2008) is eight. We at-
tempted to compare with CNVphaser using the same number of sites as presented
previously, but we found that the scale of our simulated dataset was not computa-
tionally feasible for CNVphaser. CNVphaser gives the posterior probability of the
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Figure 5.4: Histogram of certainty scores and switch error rate in each bin from
the Finnish dataset. The red circles indicate average switch error rates within each
histogram bin. The error bar of each switch error rate is based on a 95% equal-tailed
Bayesian interval given the prior Beta(1/2, 1/2). The number on the top of each cell
graph represents copy numbers at a pair of heterozygous sites (first digital number
is the copy number at the first site and second is the copy number at the second
site).
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possible haplotypes given the observed genotypes and we selected the haplotype with
the highest probability as the inferred haplotype. We show the number of individu-
als whose genotypes are not correctly phased at any heterozygous sites in Table 5.4.
The CNV genotypes at three sites are all correctly phased by both our program and
CNVphaser. For the genotypes at eight sites, the results from polyHap show that
only one individual has a switch error over all the sites while most of the inferred
haplotypes from CNVphaser are incorrect. The allele configurations are incorrectly
inferred in most heterozygous sites by CNVphaser. The simulated dataset has 3
individuals whose genotypes have deletions at all eight sites. CNVphaser tends to
infer a deletion haplotype at each site for each individual.
Table 5.4: Comparison between our method and CNVphaser
Number of individual having switch error
Number of sites Our method CNVphaser
3 0 0
8 1 24
Inference of haplotypic phase of SNPs within copy number states (in-
ternal phasing)
Internal phasing can be considered as a tool for further investigating haplotypic
phase of duplicated alleles locally. Thus we report the switch error rate at the sites
which have the same copy number. Note that here we only consider up to a single
copy of amplification at the genotype level. Table 5.5 gives the switch error rate
between a pair of consecutive heterozygous sites which have the same copy number.
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The count of each pair of copy number is shown in parentheses. For both French and
Finnish datasets, the error rates are ≤ 0.08 for locally inferring haplotypic phase of
duplicated alleles.
Table 5.5: Switch error rate for internal phas-
ing with same copy number
CN on a pair sites
1 → 1 2 → 2 3 → 3
French dataset 0 0.005 0.070
(34) (1034) (3514)
Finnish dataset 0.002 0.056 0.080
(351) (864) (229244)
5.6 Discussion
We have presented a method for inferring haplotypic phase for CNV and SNP geno-
type data among unrelated individuals. Our method allows CNV regions and ploidy
to vary along the sequence and across the individuals. Also, predefined block bound-
aries are not required in our model. Our program accommodates both CNV and
SNP genotype data and infers missing genotypes and haplotypic phase for both types
of data. One advantage of our model is that it exploits the correlation (such as LD)
between duplication states and flanking SNPs when inferring CNV haplotypes.
The results from the simulation study demonstrate that our program provides accu-
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rate estimates of missing genotype imputation, allele configuration prediction, and
haplotypic phase for both CNV and SNP data locally. Our method gives the im-
putation error rate less than 0.09 for the missing genotypes with 1,2,3 and 4 copies
of alleles. Also, our method provides accurate estimates of allele configurations on
a pair of haplotypes, which gives the error rate less than 0.19. Our method give
encouraging results for inferring CNV haplotypic phase over different copy numbers
at heterozygous sites. Although there are several situations where the switch error
rate is greater than 0.3, this might result from the rare haplotypes (observed on the
pairs of heterozygous sites) in the dataset. For these cases, the accuracy could be
improved when increasing the samples with uniform regions of CNVs. Also, with
the consideration of the certainty rates, the reliable estimates can be identified. In
general, the higher certainty rate indicates the more accuracy of the estimate.
We have shown that our program outperforms CNVphaser on the dataset containing
8 CNV sites. Attempting to run CNVphaser on the dataset with 1106 markers on
each of 24 individuals failed to produce results due to computational demand.
Our program provides two different levels of CNV phasing, non-internal and internal
phasing. For internal phasing, the individual can be considered as polyploids, and
thus the phasing precess is similar to what we described in polyHap Su et al. (2008b).
With this flexible feature, our program allows one to choose a suitable phasing level
for the specific purpose of the study. About the computation of our program, the
computing time for the French dataset with nine ancestral haplotype states and
10 repetitions of the EM training algorithm (containing 1106 markers on each of
24 individuals) was approximately 0.8 hours on a 8GB computer while the Finnish
dataset (containing 2149 markers on each of 347 individuals) took 1.5 hours on a
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16GB computer.
Haplotype information is useful for genetic analyses. New-generation DNA sequenc-
ing technologies, capable of processing millions of sequence reads in parallel, enable
us to conduct comprehensive analyses of genome-wide CNV with low cost and high
throughput sequencing data. With the increasing number of CNV regions identified
and the improving technology for genotyping CNVs, our program is a useful tool
for CNV haplotype analyses.
Chapter 6
Future Research Directions and
Conclusions
6.1 Conclusions
In this thesis, we proposed a HMM based method for disease association mapping
and haplotype inference. We employed the HMM to model the underlying haplotype
structure which is assumed to be a mosaic of ancestral haplotypes. The advantage
of using the HMM is that the block boundaries are flexible along the sequence. A
pre-defined block boundary is not required in our model. Although the appropriate
number of ancestral haplotypes is unknown, our simulation study shows that our
method performs well with eight ancestral haplotypes.
The first application of our model (implemented in AncesHC) is to cluster haplotypes
into ancestral haplotypes from genotype data and test each of ancestral haplotypes
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for disease association. We applied our method to a mouse dataset as well as a
human dataset with the simulated disease status. The results show that AncesHC
is more powerful than the single SNP test—the Armitage trend test as well as a
haplotype clustering based method—CLADHC in most of our simulation scenarios.
In the second application (implemented in polyHap), we used this HMM based
method to predict missing genotypes and to infer haplotypic phase from polyploid
genotypes. In the simulation study based on the WTCCC dataset, we considered
diploid, triploid and tetraploid organisms. The results show that polyHap provides
accurate inferences of missing genotypes and haplotypic phase of polyploid geno-
types. We also applied polyHap to a small tetraploid potato dataset and compared
results with those from SATlotyper which is only applicable for a dataset with sev-
eral sites of each individual. PolyHap outperforms SATlotyper in terms of the switch
error rate.
In the third application (modified polyHap), we further extended the model to infer
CNV haplotypes and imputed CNV genotypes. Our program provides two levels
of phasing (internal and non-internal phasing) and allows the copy number change
along the sequence as well as across the individuals. The results from simulation
study show that our program performs well in term of the switch error rate and the
imputation error rate.
For all three applications, the certainty rate of each estimate is calculated, which can
be used as a scalar of accuracy of our estimates and incorporated in the subsequent
analysis. The Baum-Welch training algorithm provides an efficient way to estimate
the parameters in the HMM. Thus, our method is able to analyse a large-scale
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dataset and potentially computational feasible for a genome-wide scale study. With
the increasingly amount of published SNP and CNV data from human and other
species genomes, our proposed method is useful for analyses of these genetic data.
6.2 Future research directions
6.2.1 Incorporating phenotypes into haplotype clustering
The disease haplotypes which are inherited from the high-risk ancestral haplotype
share more similarity than the normal haplotypes because of the more recent com-
mon ancestry shared by the disease haplotypes. Thus, one potential improvement
of the accuracy of clustering is to include the disease phenotype in the haplotype
clustering process. This idea can be exploited by considering the joint emission
probability of genotypes and phenotypes:
p(gm, D|sm) = p(gm|sm)p(D|gm, sm) = p(gm|sm)p(D|sm) (6.1)
where D is the disease phenotype; gm and sm are the same definition as in the
previous chapters (the genotypes and ancestral haplotypes at marker m). Assume
that the disease phenotype is the observed disease status, 1 for the cases and 0 for
the controls. The emission probability p(1|sm) of being a case given the ancestral
haplotype sm at marker m can be considered as a parameter estimated from our
EM training algorithm while p(gm|sm) is the same as described in equation (2.4).
Subsequently, p(0|sm) can be easily obtained by 1− p(1|sm).
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6.2.2 Long-range phasing
Many statistical methods for inferring haplotypic phase from genotype data are
developed. Most of them explored the correlation between SNPs within the LD
block, and thus have less accuracy for inferring haplotypic phase at the markers
across LD blocks. One way to assess the performance of haplotype inference is to
calculate the switch error rate (see Chapter 4) between the pair of heterozygous
sites along the sequence, which is the assessment of local phasing. Another way is
to calculate the individuals error rate—that is, the proportion of individuals whose
haplotypic phases are not correctly inferred on any pairs of heterozygous sites along
the investigated sequence, which can be considered as the assessment of long-range
phase. In general, the individual error rate increases with the number of SNPs.
To overcome this limitation of the current methods, one of our future research
direction is to modify our method to be able to infer long-range of haplotypic phase
correctly. Kong et al. (2008) have explored this idea of long-range phasing on the
icelandic population based on a rule-based method. Kinship in this population is
high enough to expect that most genotyped individuals share a region of IBD. Based
on this IBD sharing, a pedigree-like relation is constructed between the proband
and part of the individuals in the population which are defined as the surrogate
relatives and parents. Haplotypic phase is then inferred from this surrogate family-
tree structure. The results show that their method outperforms fastPHASE in
terms of the discrepancy rate (individual error rate) in the trio test when phasing a
chromosome region covering 1000 SNPs.
However, this approach is a rule-based method rather than a model-based method.
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This might limit the application and generalization of the method to other studies.
Also, applying this method to other population may not perform as good as to the
icelandic population because the kinship in a population may not as strong as it in
the icelandic population.
To explore the idea of long-rang phasing in our model, one proposed approach is
to modify the transition probability between the hidden states in the HMM. We
assume that the observed haplotypes share the long-range of ancestral haplotype.
That is, the transition event between two states occurs less often.
6.2.3 DArT marker and trisomy data
We would also like to keep working on the DArT markers and trisomy data which
were introduced in Chapter 4. The preliminary results seem to be promising. In
terms of the application to the DArT markers, we have shown that our method
performs well in the simulated datasets. Now, we are trying it on a real dataset con-
taining rye genotypes from DArT markers provided by Diversity Arrays Technology
Pty, Ltd. This dataset contains the raw intensity score, from which the heterozygous
and homozygous genotypes at a dominant marker can be inferred. This provides
us a reference to assess performance of our method for predicting the heterozygous
and homozygous genotypes at a DArT marker.
In terms of the application to the trisomy data, the results show that our method
is able to infer haplotype correctly on a real trisomy dataset according to the trio
test (by comparing the inferred haplotypes in the child to the parents). According






Nondisjunction in meiosis I Nondisjunction in meiosis II 
Figure 6.1: Illustration of nondisjunction in meiosis I and II. The two identical
haplotypes are created in one of the gametes because of the nondisjunction in meiosis
II while two distinct haplotypes are observed in the gamete when nondisjunction
occurs in meiosis I.
in meiosis I, which results in three distinct haplotypes, while 23% are caused by
nondisjunction in meiosis II, which leads to have two identical haplotypes in three
set of chromosomes (Figure 6.1). In the future, we would like to extend our model to
be able to predict not only haplotypic phase of genotypes but also nondisjunction-
phase in meiosis for an individual.
Here I briefly describe the idea of how to modify our model (Figure 6.2). First, the
full probability (see equation 2.5) of each observed genotype sequence is calculated
given that the individual is affected by nondisjunction in meiosis I and II respectively
(Step 2). Note that the genotypes are considered as diploids if nondisjunction occurs
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in meiosis II and triploids for nondisjunction in meiosis I. The meiosis phase of
nondisjunction for each individual with the highest probability is chosen given the
genotype data (Step 3). The transition and emission probabilities are then updated
in the EM training algorithm on the basis of the haploid model (Step 4). For the
next iteration of the EM training algorithm, the transition and emission probabilities
in the haploid model are paired into diploids for nondisjunction in meiosis II and
triploids for nondisjunction in meiosis I. The meiosis phase of nondisjunction again
with the highest probability is chosen to update the haploid model. The iteration of
the training stops when the logarithm likelihood probability meets the pre-defined
criteria or the number of iterations reaches 25 (Step 5 and 6).
Alternatively, at the step 3 and 4 in Figure 6.2, we update the parameter estimates
in the training process using the information from both meiosis phases of nondis-
junction simultaneously rather than choosing one phase with the highest probability
(shown in the red box). During the training process, the expected counts of the emis-
sion and transition probabilities are calculated given that the individual is affected
by nondisjunction in meiosis I and II respectively, and these counts are weighted by
the full probabilities calculated in the step 2. After training, the estimates of the
parameters in the model are obtained. The full probability of an individual given
nondisjunction in meiosis I and II can be calculated respectively using these param-
eters estimates in the forward algorithm, and then meiosis phase of nondisjunction
can be inferred by choosing the one with the highest probability.
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Figure 6.2: This graph explains how we modify the algorithm to infer the haplotypic
phase as well as meiosis phase of nondisjunction. The main difference from the
previous training process is that the full probability of each individual is calculated
given the individual affected by nondisjunction in meiosis I and II respectively,
and meiosis phase of nondisjunction of that individual with the higher probability
is chosen to proceed the rest of the training process. The red box describes the
second way of updating model parameters by considering both meiosis phases of an
individual simultaneously.
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